OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2025-12-31-accounts

A year of progress and change

Contents

Contents
Who we are and what we do 3
Foreword 5
Report of trustees
Educating physicians and supporting them to fulfil their potential 7
Improving health and care and leading the prevention of ill health across communities 12
Influencing the way that healthcare is designed and delivered 17
Our enablers 22
Looking ahead 25
Our structure, governance and management 28
Statement of trustees’ responsibilities 31
Officers and key staff of the RCP 33
Summary of income and expenditure 37
Financial policies 38
Financial review 42
Independent auditor’s report to the trustees of the RCP 44
Financial statements 47
Awards, fellowships and donors 79
Administrative information 81

2

Who we are and what we do

About the RCP

The Royal College of Physicians (RCP) is a professional membership body for physicians, with around 40,000 members and fellows across the globe working in hospitals and communities across 30 medical specialties. Physicians diagnose and treat illness, and promote good health. They care for millions of medical patients with a broad range of conditions, from asthma and diabetes to stroke and dengue fever.

Everything that we do at the RCP aims to improve patient care, reduce illness and promote health. Our work is patient centred and clinically led. We drive improvement in the diagnosis of disease, the care of individual patients and the health of the whole population, both in the UK and across the globe. We work to ensure that physicians are educated and trained to provide high-quality care. We also develop doctors to become leaders, providing advice and expertise to deliver service improvements across the NHS and more broadly.

The RCP maintains and sets standards by regularly reviewing clinical guidelines, developing best practice frameworks, and providing accreditation for healthcare organisations and services. Through collaboration with expert committees and consultation with our members, we ensure that standards reflect current evidence and meet the evolving needs of patients and the medical profession.

Partnership with patients

Our Patient and Carer Network (PCN) was established in 2004. A network of volunteers throughout England and Wales, PCN members are involved in the full range of RCP activities.

Their invaluable contribution helps to ensure a continuous focus on patient-centred care, patient safety and health improvement. Partnership is key, with patients and carers providing a vital range of lived experiences and perspectives, which help to inform the design and delivery of healthcare.

Our strategy

The RCP is both a professional membership body and a registered charity. Our new 2026–30 strategy reflects our responsibilities in both of these roles and was developed following extensive consultation with our members, stakeholders and staff.

Marking a significant moment of renewal for the college, the new strategy is structured around four clear priorities – connection, standards, voice and renewal – and sets a clear direction for the RCP for the next 5 years. It focuses on what matters most: support for the profession, a stronger and more connected community, and a clear, credible voice shaping the future of healthcare.

It also recognises the internal work required to achieve this, including modernising the organisation, strengthening governance and building long-term financial resilience.

3

Public benefit

The RCP was established by royal charter from King Henry VIII in 1518. It is a registered charity, and the trustees are mindful of their duty to ensure that the charity’s purpose accords with the objects set out in its governing document (the charter).

Uniquely for the time, through the charter the king established the RCP in perpetuity as a professional body in the name of the public benefit. He empowered it to set standards by regulating practice, to protect the public.

Today the RCP continues to focus its work to support high standards of medical training and patient care through activities within the meaning of charitable purpose, as defined by the Charities Act 2011, that are carried out for the general public benefit.

In particular, most of our activities fall within the purposes of the advancement of health or the saving of lives; the advancement of education; and the advancement of the arts, culture, heritage or science.

Our work in these areas is made possible through the involvement of our fellows and members wherever they work, in the UK or overseas, and is summarised annually in this report.

4

Professor Mumtaz Patel President

Dr Diana Walford CBE Chair of the Board of Trustees

Jonathan Brüün Chief executive officer

Foreword

We are pleased to present the 2025 annual report for the Royal College of Physicians (RCP), which reflects on a year of progress and change.

It’s been a significant year for RCP leadership, with the election of a new president, the appointment of a new chair of the Board of Trustees and of a new chief executive officer. Each of us brings fresh perspective, along with a commitment to drive positive change for the RCP and to work together effectively as a team. Following a difficult period for the college, last year was spent on rebuilding the confidence of our members and reasserting the RCP as an authoritative and trusted voice in medicine and healthcare.

We would like to express our sincere thanks to the many members, fellows, officers, staff and volunteers whose commitment and expertise have been crucial in supporting our work and strengthening our community throughout 2025.

An important milestone was the extension of voting rights in elections for RCP vice presidents and councillors: a historic vote of fellows in October gave collegiate members a democratic voice in the leadership of their college for the first time in our long history.

Other key highlights included our popular Medicine and Med+ conferences, the Excellence in Patient Care Awards, and our next generation campaign, which put early-career doctors at the heart of national debate on medical training and workforce reform. High-profile policy work featured a visible campaign to end corridor care, influenced parliamentary debate and contributed to an NHS England review of postgraduate medical training, while new resources included job planning guidance, a report on reimagining specialist outpatient care and the launch of a new Register of Fellows to highlight the breadth of our expert community.

Financially, the RCP ended the year with a small surplus, which reflects careful cost control across the organisation. Our goal now is to ensure that the RCP is financially sustainable well into the future to support the delivery of our strategic framework, which is firmly centred on the needs of our membership.

Our new 5-year strategy for 2026–30 follows wide consultation with members, stakeholders and staff. We heard repeatedly that our members want a college that strengthens community and belonging, delivers excellent education and the highest standards, and speaks with a clear, credible voice for the profession. The strategy aims to deliver on that mission as we look ahead to 2026 and beyond. We are confident that, together with our members and fellows, we will shape the future of medicine to benefit patients in the UK and around the world.

5

This report presents our activities, significant achievements and successes in 2025

Report of trustees

The trustees of the RCP are pleased to present their annual report for the year ended 31 December 2025. The report presents the RCP’s activities, significant achievements and successes in 2025.

As our new strategy applies to our work from 2026, this report covers activities and achievements under our previous strategic priorities of educating , improving and influencing . These priorities are underpinned by a set of five ‘enablers’: close engagement with the RCP membership, patient and carer involvement, a focus on diversity and inclusion, good governance, and working in a sustainable way.

The report also covers highlights of key activities carried out by the Federation of the Royal Colleges of Physicians of the UK.

The Federation is a collaboration between the Royal College of Physicians of Edinburgh, the Royal College of Physicians and Surgeons of Glasgow, and the RCP. Together, the three colleges represent more than 60,000 physicians worldwide.

The Federation develops and delivers services to support doctors at every stage of their careers, focusing on examinations, training and continuing professional development.

6

Educating physicians and supporting them to fulfil their potential

7

We strove for excellence in the training and continuing professional development of physicians throughout their careers

Our activities and achievements

We provided a wide range of professional development opportunities for doctors of all grades and specialties, as well as for the wider multiprofessional teams. With a world-class reputation for our educational programmes, we supported physicians at every career stage from medical students to consultants. We delivered bespoke, postgraduate examinations to clinical professionals from across the healthcare landscape, both in the UK and internationally.

‘Education, training and wider CPD

are not only vital for our own personal development but also support the next generation of physicians to deliver excellent patient-centred care. Our programmes also foster connection and community through sharing experiences and learning from one another.’

– Professor Mumtaz Patel, vice president for education and training

Supporting physicians throughout their careers

Our annual conferences Medicine 2025 and Med+ provided key professional learning and development opportunities for over 3,150 physicians, with keynote speakers including Professor Kevin Fong, Dr Imogen Grant and Dr Birju Bartoli.

We added a raft of new educational workshops to our expanding portfolio in 2025, covering topics such as quality improvement and human factors in healthcare, as well as a revamp of our courses focused on leadership.

A total of 1,500 delegates attended our popular regional face-to-face Update in medicine conferences across the UK. An impressive 99% of delegates said they would recommend these events to their peers, reflecting strong confidence in learning that ultimately benefits patients.

Over 2,000 doctors registered for our Call the medical registrar online conference, with 95% of attendees saying the content directly influenced their clinical practice. The event was highly commended in the membership engagement category at the 2025 Memcom Awards.

RCP Launchpad, a unique collection of resources and bite-sized videos, together with our new consultants forums, supported more than 500 new consultants, early-career SAS doctors and senior resident doctors transitioning to the next stage of their career. Our quality improvement workshops for consultants also continued to be popular, running five times a year.

RCP Medicine podcasts went from strength to strength, exploring a wide range of topics of relevance to physicians and healthcare teams, with recent episodes focusing on health inequalities in pregnancy, myositis, sustainability in the NHS and sickle cell disease. The number of downloads is increasing year on year.

8

The Federation of the Royal Colleges of Physicians of the UK (the Federation) is defining the requirements and functionality for its new continuing professional development (CPD) approval system. Four new CPD reviewers were successfully recruited and trained, and two new e-platform providers will support multidisciplinary learning and enable recognised qualification pathways.

Assessment and exams

Our Assessment Unit, based in The Spine in Liverpool, is responsible for delivering PACES, the practical assessment of clinical examination skills for doctors, in the UK in line with the standards set for MRCP(UK) as part of the RCP’s role as a partner of the Federation. We also oversee the development, governance, and operational management of the Physician Associate Registration Assessment and the Diploma in Geriatric Medicine.

All examinations are delivered in accordance with the standards set by the relevant regulatory bodies, and candidates are supported throughout the assessment process – from application through to certification.

We ran PACES in six new centres across the UK. A new host was also recruited to run PACES in our state-ofthe-art assessment facility at The Spine, increasing the number of PACES centres run there to four.

The MRCP(UK) diploma is essential for all physicians who wish to train in a medical specialty in the UK. The Federation delivered assessments for more than 26,000 candidates across 30 countries and handled 40,000 exam-related enquiries throughout the year. There were over 370,000 unique visitors to the Federation website.

Over

3,150

paying delegates attended our annual conferences Medicine 2025 and Med+

We ran over

200

educational programmes and workshops, attended by over 3,500 people

11

doctors completed the inaugural cohort of our Aspiring Medical Directors Programme and a further 15 started the second cohort

9

An MRCP(UK) Part 2 written exam results processing issue was identified in early 2025. Incorrect results were communicated to 283 candidates who took the exam in September 2023.

This caused considerable distress among those affected. As well as extending its sincere apologies to affected candidates, the Federation responded by offering one-to-one support from senior clinicians to guide them through their next steps, refunding exam fees, and providing free resits, additional examination slots and access to welfare resources. Study support funding was also offered to those required to resit the exam.

The Federation commissioned an independent external review into the circumstances that led to the error. Professor John McLachlan’s report was published in November 2025 and will be used as a roadmap to restore confidence in the exam systems and governance. Work to address the 22 recommendations started during 2025 – at the time of writing 10 have been actioned, while others are in progress. This work will continue through 2026.

Training and curriculum development

The Federation’s development initiatives included:

The new internal medicine quality criteria were launched at the GMC’s London offices in March and featured high-profile presenters and a focus on achieving quality and consistency in the provision of training.

We facilitated over

4,300

assessments through our Assessment Unit, including over 2,200 PACES exam slots

Nearly

3,000

people enrolled onto one of our e-learning modules

Our RCP Medicine podcasts were downloaded more than 140,000 times, over

10%

more than in 2024

10

We launched a new Diploma in Global Health in collaboration with Médecins Sans Frontières

Global work

Our new Diploma in Global Health established in partnership with Médecins Sans Frontières launched in the spring and has received very positive feedback so far. It aims to enhance patient care and improve the organisation of health services in resource limited and humanitarian settings. The first exam was taken by 240 doctors across 58 countries, and 99% of candidates said they would recommend it to a colleague.

We delivered a 1-week residential palliative care course in Karachi, Pakistan continuing our work to create additional global capacity in this vital specialty.

We delivered six workshops outside of the UK on topics including leadership, audit and improvement methodologies and clinical supervision. We also continued our partnership with BMJ India in the delivery of our 6-month certification course on diabetes, while exploring expansion into new areas of disease management.

To increase international assessment capacity, the Federation launched three new PACES sites in Egypt, Pakistan and India, as well as approving two new PACES sites for launch in 2026 in Saudi Arabia and Brunei.

The Federation delivered IMT-equivalent training to 290 doctors across 11 international centres, supporting high-quality physician education globally. It also provided a record 3,930 international PACES places, the highest level of availability to date. An overseas faculty development day received excellent feedback from participants.

There were over

20,000

eLibrary logins via OpenAthens

1,500

delegates attended our popular regional Update in medicine events

11

Improving health and care and leading the prevention of ill health across communities

12

We improved the quality, outcomes, safety and experience of patient care by developing and setting standards

Our activities and achievements

We worked collaboratively to support clinical teams to deliver improvements in healthcare. Our audit and accreditation programmes continued to grow, and empowered services to benchmark performance, adopt evidence-based improvements and celebrate excellence. By facilitating independent reviews and providing expert guidance, we supported organisations in fostering a culture of safety, collaboration and ongoing development across the NHS.

‘The RCP sets standards for clinical care and supports physicians to improve the care they provide. We work collaboratively to measure care, provide expert guidance, share improvement initiatives and celebrate excellence so that physicians can deliver better outcomes for patients.’ – Dr Hilary Williams, clinical vice president

Audit, accreditation and service review

We continued to be commissioned by HQIP to deliver two national clinical audit programmes: the Falls and Fragility Fracture Audit Programme (FFFAP) and the National Respiratory Audit Programme (NRAP).

FFFAP includes three workstreams, which focus on inpatient falls, fracture liaison services and hip fractures. We made 12 national recommendations to improve care for patients who have fallen in hospital or experienced a fragility fracture. A total of 170,000 patient cases were submitted to FFFAP databases, and the programme expanded to include Jersey for the first time. The National Audit of Inpatient Falls also expanded to include other serious fractures and head injuries, seeing a doubling in case numbers submitted to support patient safety initiatives.

Quarterly reporting continued to support the downward trend in mortality since the National Hip Fracture Database was set up in 2007 (from 11% to 5.3%).

Our popular FFFAP webinars focused on using data for local improvement, how to engage patients in quality improvement and understanding clinical standards. Twelve newsletters, sharing improvement case studies, FAQs and literature reviews, were circulated to over 4,000 clinical audit users with an open rate of 32%.

NRAP played a pivotal role in shaping clinical guidance and driving improvements in respiratory healthcare. The audit contributed significantly to the development and updating of the 2025/26 best practice tariff (BPT) for adult asthma and COPD admissions, with our BPT charts widely used throughout England to monitor compliance and enhance patient outcomes. A key recommendation from NRAP to establish workforce

13

We held

12

webinars as part of the Falls and Fragility Fracture Audit Programme, engaging with over 1,800 attendees

We captured over

ratios for children and young people’s asthma services was adopted by the British Paediatric Respiratory Society, demonstrating our influential reach. The NRAP database has grown substantially, now containing hundreds of thousands of patient records across COPD, adult and paediatric asthma, and pulmonary rehabilitation (PR), providing a robust foundation for quality improvement and research.

NRAP also focused on professional development, offering PR community of practice sessions and training respiratory teams to use audit data for local improvement. Our health improvement programme engaged nine volunteer coaches to support 25 respiratory teams through targeted coaching and workshops. A national symposium at the British Thoracic Society conference focused on translating audit data into valuable insights for clinicians. In research, the NRAP Research Committee published multiple abstracts and papers, including award-winning work at the American Thoracic Society conference.

Our accreditation workstream, which assesses the quality of clinical services against standards, continued to grow. More than 300 services have been awarded accreditation across our six programmes, comprising endoscopy, allergy, liver services, diabetes care, pulmonary rehabilitation and immunodeficiency. Almost 500 additional services have registered and are actively working towards accreditation.

In endoscopy, over 2,500 participants attended our training courses, and we launched a new administrative and clerical framework for those working in the field. We accredited more than 60 bowel cancer screeners, ensuring that clinicians carrying out colonoscopies for bowel cancer screening meet established standards. We launched a paediatric global rating scale to measure the quality of endoscopy services for patients under 16. Finally, we worked with over 150 assessors to carry out site assessments across the UK, including medical, nurse, lay and management assessors.

2.3m

procedures in the National Endoscopy Database

We supported

25

respiratory teams with targeted coaching and workshops

We delivered

11

invited reviews across six specialties

14

Our Excellence in Patient Care Awards celebrated the achievements of our members and fellows

Our Invited Reviews Service supports healthcare organisations requiring independent advice. The service works with specialist societies and professional bodies to bring together the expertise of physicians, surgeons, clinical nurse specialists, pharmacists and allied health professionals. In 2025, we delivered 11 invited reviews across six specialties, providing independent and expert advice on issues including patient safety, individual behaviours and teamworking, governance and service configuration.

Enabling improvements in care

The RCP’s flagship Chief Registrar Programme continued to be highly successful, supporting resident doctors to lead positive change and impact in their trusts, underpinned by our development programme. We also provided ongoing opportunities for development and engagement to alumni of the programme.

We continued to support workforce development through specialist programmes in obstetric medicine, gender identity healthcare, and supporting the needs of adults with learning difficulties. These programmes, funded by the government, enable the development of clinicians to a high standard in these areas so that patients receive the best possible care.

The first of four clinical summits focused on advancing the management and prevention of cardiometabolic disease, with over 30 experts from across the healthcare landscape.

We held our annual Excellence in Patient Care Awards, which received 150 applications across 10 categories this year. The awards generated hundreds of healthcare quality improvement stories and case studies. They provide a unique opportunity to celebrate and showcase the work of our members and fellows, and play a vital role in spreading innovative practice and supporting the spread of healthcare improvement nationally.

We celebrated

10

years of IQAS (allergy) and 25 years of QPIDS (immunodeficiency) accreditation

More than

300

clinical services received accreditation across our six programmes

15

We launched new guidance to support job planning for physicians

Guidance and resources

We published Prescription for outpatients: reimagining planned specialist care , which sets out a long-term vision to transform how planned specialist care is delivered. It argues that the current outpatient model is no longer sustainable or aligned to modern patient needs.

We welcomed

80

resident doctors to our flagship Chief Registrar Programme, supporting them to drive improvements in the NHS

Our new guidance aims to empower consultant physicians, specialist doctors, clinical leaders and service managers to work collaboratively on job planning for physician teams. Empowering physicians advocates for a more balanced flexible and realistic approach that will protect patient safety and improve workforce retention.

16

17

We significantly strengthened our role as the authoritative voice of physicians

Our activities and achievements

We secured major policy wins. Government and NHS commitments on outpatient reform, competition ratios and climate action, all RCP priorities, were reflected in documents such as the national medical training review phase 1 diagnostic report and 10 Year Health Plan. We influenced parliamentary debate, which led to the introduction of a bill to prioritise UK graduates for training places, and we ran high-profile national campaigns on corridor care, medical education, air quality, health inequalities and prevention.

We delivered an influential year with increased national media coverage. We continued to expand the reach and impact of our journals, conferences and digital platforms, supporting clinical improvement and professional leadership.

Policy and campaigns

In 2025 we continued to promote, advocate and campaign on the issues that matter most to physicians, focusing on workforce, education and training, alongside action on corridor care, prevention of ill health and health inequalities. New agile working groups, snapshot surveys, position statements and policy reports were used to reinforce our membership’s priorities.

We shaped the national conversation on medical training reform. Through our next generation campaign, a national survey of resident doctors and sustained media and parliamentary engagement,

we helped secure a national review of postgraduate training and commitments to address competition ratios and expand specialty training places.

A strong and visible campaign on corridor care used member surveys, frontline testimony and clinical guidance to hold government and NHS leaders to account. Our calls for transparency directly contributed to commitments to publish corridor care data (from May 2026) and to end the routine use of temporary care environments. We also led work on outpatient reform, with our Prescription for outpatients report influencing NHS and government commitments to transform planned specialist care as part of the shift from hospital to community.

‘This year we have reasserted the RCP as a credible, authoritative and trusted voice in healthcare. By grounding our work in members’ experience and clinical evidence and engaging with government and key stakeholders, we have helped shape national policy on workforce, training, prevention and service reform at this critical moment for the NHS.’

– Professor Tom Solomon CBE, academic vice president

18

We attended

174

influencing meetings with government, MPs, peers, the NHS and other national bodies

We had

On public health and prevention, we published a major report on air quality, a refreshed position statement on obesity, and continued to campaign on tobacco, sustainability and alcohol. We gave evidence to parliamentary committees and worked in coalition with other health organisations. Our report A breath of fresh air significantly shaped national debate on air pollution as a public health issue.

We formally responded to a number of external consultations covering policy, clinical and professional issues, including consultations on the Leng review into the safety and effectiveness of physician associates and anaesthesia associates, the postgraduate medical training review and the House of Commons Public Bill Committee on the Terminally Ill Adults (End of Life) Bill.

We strengthened our position in the devolved nations, publishing a manifesto for the 2026 Senedd elections and a report on integrated care in Wales, alongside hosting roundtables in Wales and one in Northern Ireland.

Media and engagement

Our media coverage more than doubled from the previous year. Putting member stories at the heart of our approach, we secured extensive national, regional and trade media coverage across print, broadcast and online outlets, positioning the RCP as a trusted and authoritative source on corridor care, workforce pressures, medical training reform, health inequalities, prevention and climate change.

We expanded onto new digital and communications platforms, including WhatsApp and Bluesky and launched new newsletters on LinkedIn, increasing the reach and impact of RCP policy positions and reinforcing the RCP’s reputation as a credible, independent voice for physicians.

52

mentions in UK parliament

We made the headlines with almost

10,000 appearances in broadcast, print and online media

There were over 989,000 site visits to our medical streaming service RCP Player

19

We put the voice of early-career doctors at the heart of national debate on medical training

We gained over

The next generation of physicians: campaign progress in 2025

Our next generation campaign put the voice of early-career doctors at the heart of national debate on medical training and workforce reform.

17,000

new social media followers

The impact factor of Clinical Medicine rose to

3.9

placing it in the top 15% of general medical journals

Commentary magazine had over 77,000 online views and moved to a web-only format

20

Almost 4,000 people visited the RCP Museum, and over 1,300 attended our exhibitions and events

Spreading best practice

Our journals, publications, conferences and events continued to support professional learning, thought leadership and member engagement, while extending our global reach. Clinical Medicine and Future Healthcare Journal maintained strong performance, with rising submissions, more than 6 million article downloads and an increased profile through broadcast and national media coverage. Clinical Medicine’s impact factor rose to 3.9, placing it in the top 15% of general medical journals worldwide. We shared member stories and showcased innovation through Commentary , which we relaunched as a web-first, interactive membership magazine.

Our annual conferences, Medicine 2025 and Med+ 2025, attracted large in-person and online audiences, with increased participation from resident doctors and other training grades, a high volume of abstract submissions and strong stakeholder attendance. A wide programme of CPD-accredited lectures, webinars, specialty events and ceremonies – including the Harveian Oration and the Christmas lecture – complemented our conference offer, supporting lifelong learning and professional recognition.

Promoting medicine and the RCP

Through our museum, archive and heritage programme, we delivered a strong programme of public engagement, exhibitions and learning activity throughout 2025, increasing visitor numbers and broadening audiences. Key exhibitions included ‘A body of knowledge’, launched alongside the ‘Making visible’ artwork installation, which highlighted the overlooked contribution of women to early printed medical texts, and earlier exhibitions such as ‘Healing words’.

A varied public programme included museum lates, lectures, family workshops, heritage tours and participation in the Open House architecture festival, which attracted over 400 visitors. Activity aligned with national moments, including LGBT+ History Month, South Asian Heritage Month and East and South East Asian Heritage Month, with several events selling out. Education and outreach continued to expand through partnerships with the British Library, school sessions and digital events.

Significant acquisitions were secured through external grant funding, including rare early modern medical texts and new oral history material, supporting future exhibitions and research. Fundraising activity expanded through the launch of our ‘Adopt a treasure’ campaign, installation of a contactless donation point and closer cross-college collaboration.

21

Our enablers formed threads that ran through and supported each of our three priorities

Our enablers

1 Membership engagement

More than 4,200 doctors and medical students joined the RCP and 787 were elected as fellows, becoming part of our influential community of changemakers. We held six new member and three new fellow ceremonies, bringing our community of physicians together to celebrate these important milestones. We also a fellowship ceremony in Chennai, India for the first time.

We launched an online Register of Fellows to showcase their credentials and help foster connections.

Regular engagement visits with senior RCP officers at hospitals in England, Wales and Northern Ireland fostered direct dialogue with clinicians, capturing local challenges, strengthening relationships and supporting regional advocacy.

We celebrated SAS week with activities including a ‘Meet the president’ session highlighting unique workforce needs and inequalities, SAS-focused leadership training, a Commentary feature on alternative training pathways, and free access to resources.

We ran survey of members and fellows to support the development of the next RCP strategy.

The Turner-Warwick lectureship was relaunched as a subscribing member-only opportunity. The number of entries increased, and the three winners will deliver their lectures at Update in medicine conferences in 2026. Our virtual poster competition for subscribing members had 350 applications, the highest number to date.

22

Two college tutor/associate college tutor (CT/ACT) network meetings with over 100 attendees were used to share best practice, raise challenges and learn from peers. These meetings, together with the CT/ACT conference, form a key part of our annual CPD for CTs and ACTs, recognising their educational contribution.

Our Advisory Appointments Committee (AAC) service supported the appointment of physicians to consultant and SAS posts in the NHS. We facilitated the attendance of representatives on 537 AAC panels, and 655 job descriptions were received and reviewed by our regional specialty advisers and regional advisers.

We provided free e-learning programmes and discounted workshop fees to our members. We also offered a free library service, access to journals and literature search service.

We launched a new RCP offer for refugee physicians, providing a welcoming professional home. We celebrated 5-years of the RCP Iraq Network and 10-years of partnership with the East, Central and Southern Africa College of Physicians.

During 2025 we were involved in the delivery of 18 events for the benefit of our members and fellows based outside of the UK. We were present in 14 locations, reaching approximately 14,870 attendees.

We hosted several visiting RCP fellows, partner organisations and health system leaders at the RCP and were involved in nine UK-based events with relevance to our international membership and UK diaspora colleagues.

We delivered 16 online events for international medical graduates, reaching 442 attendees.

We hosted three Senior Physicians Society events for our retired community, focusing on scientific, cultural and educational themes.

2 Working with patients

The RCP Patient and Carer Network provided support and expertise for many of our projects, including:

Patients are also involved in our audit workstreams. FFFAP worked closely with patient and carer panel members across all aspects of the programme. NRAP is bringing the respiratory adult patient panel in house, to bring the patient voice and experience into the heart of our decision making.

Patients with lived experience contributed to the development of the content for our education programmes.

We recruited 49 new volunteer patients to our assessment patient bank at The Spine. These volunteers generously give their time to help facilitate the clinical skills training of doctors.

Our Invited Reviews Service developed processes to incorporate the experiences of patients and their relatives in its work. A medical director day included talks on the importance of listening to patients in the planning and delivery of services and adopting traumainformed approaches to family involvement in review processes.

The Federation engaged new lay representatives for a number of boards and committees.

3 Diversity and inclusion

New employees continued to be invited to equality and diversity training as a mandatory part of their induction programme, and then to take part in ‘renewal’ training every 3 years.

Our equality, diversity and inclusion policy continued to ensure a balanced programme of speakers, presenters and chairs at our events.

Equality, diversity and inclusion were included as key topics in our education workshops and programmes, as well as our examiner training.

We prioritised gender pay transparency and action and were pleased to show a reduction in our gender pay gap (GPG) in 2025. Our GPG report reviewed our workforce profile, highlighting the distribution of women and men across pay quartiles and noting ongoing challenges, especially in senior roles.

Two of our FFFAP audits – the National Hip Fracture Database and Fracture Liaison Service Database – reported on health inequalities data.

The Federation continued its focus on effective interventions to mitigate differential attainment.

4 Governance and stakeholder engagement

We held elections for RCP president, clinical vice president and elected councillors. Turnout from the fellowship was over 36%, the highest since 2002. Elections-focused engagement activity included a special edition of Commentary and presidential hustings.

23

It was all change for the three most senior leadership positions in the RCP. Professor Mumtaz Patel was elected as president in April, Dr Diana Walford was appointed as the chair of our Board of Trustees in March and Jonathan Brüün joined us in January 2026 as chief executive. All bring a wealth of leadership experience in healthcare to their roles.

We delivered The King’s Fund independent learning review recommendations, outlining our achievements in a short report. A year of transformation captures a year of real change and progress at the RCP.

We commissioned an external review of our governance structure, focusing on the effectiveness of the trustee board, its relationship and interactions with RCP Council, culture and conduct, governance structures, decision-making and oversight and strategic alignment of the board and Council. The findings of the external review will be considered and identified issues addressed during 2026.

We strengthened transparency, engagement and trust with our members by introducing a new open section in Council meetings and publishing high-level meeting summaries on our website. We also published new standard operating procedures for general meetings of fellows.

We launched our first People strategy and made strong progress against the year 1 priority actions and targets. The strategy sets out a framework for a resilient, healthy and sustainable workforce and for strengthening the employee experience.

We improved our IT systems to help us engage with our members more effectively, including work on a major upgrade to our customer relationship management (CRM) system.

The Federation published the findings of an independent review into the error that occurred after the MRCP(UK) Part 2 written examination held in September 2023, and completed the discovery phase of the exams management system to mitigate risks and enable more efficient delivery.

Extending voting rights

Collegiate members of the RCP were given a democratic voice in the leadership of their college for the first time in over 500 years.

As part of a constitutional review, we held a wide consultation with our membership on modernising the college’s election processes. Council-approved proposals were discussed at our AGM, and a post-meeting ballot with a turnout of nearly 30%, voted to broaden voting rights for the elections of vice presidents and councillors to collegiate members.

In a (non-binding) vote, more than 75% of fellows who voted said that the RCP should explore amending the Medical Act 1860 to remove restrictions and extend voting rights for the election of the president.

5 Sustainability

A summary of the challenges and opportunities relating to the RCP’s London estate was shared with fellows, members, staff and stakeholders, inviting their views to collaboratively explore future options that balance our rich heritage with modernisation.

We held a number of workshops, events, committee and board meetings virtually to reduce the requirement for travel and impact on the environment.

In London we carried out upgrades to the heating and cooling systems to improve energy efficiency, sustainability and cost-effectiveness. We also improved the emergency lighting, introducing a software-based system and LED lamp upgrades, and replaced a 25-year-old stove to increase capacity and energy efficiency. We were successfully reaccredited with ISO14001, the standard for environmental management systems, and received the gold standard for the management of waste streams from our waste provider.

In Liverpool, The Spine is on track to achieve recertification of the WELL Platinum standard, a globally recognised benchmark for healthy buildings. An evaluation exercise highlighted the building as a standout example of user experience and sustainability performance. Maintenance work included replacing fan coil units and repairing fire doors, and we negotiated a 12.5% reduction on our supply of services contract.

Our Meetings and Events team had a record-breaking year, with commercial sales generating a surplus of £1.4m. Commercial activity was boosted by upgrades to the meeting rooms at the RCP at Regent’s Park.

The UK Health Alliance on Climate Change (UKHACC) commitments were developed to help health organisations take steps to mitigate and adapt to climate change. The RCP signed up to the commitments in 2024. In 2025, we published two report cards outlining our activities to improve environmental sustainability as an organisation under each of the 11 commitments, covering our finances, catering and buildings, as well education and influencing.

24

Our plans for 2026 will be organised under our four new strategic priorities

Looking ahead

The RCP’s new strategy for 2026–30 will shape our identity and actions in the coming years. Our mission is to empower members and fellows to drive positive change for medicine and for patients through community, learning and advocacy. To realise this mission, the strategy centres on four key priorities developed following extensive consultation. Our planned activities for 2026 are grouped under these new priority areas:

Priority 1: Supporting our membership and leading our community

25

Priority 2: Ensuring excellence in education and setting the highest standards

Priority 3: Using our voice to advocate and shape the future of medicine

26

Priority 4: Building organisational resilience and achieving responsible growth

The Federation will:

27

Our structure, governance and management

The RCP is a registered charity (no. 210508), incorporated by royal charter dated 23 September 1518, affirmed by an act of parliament in 1523. The charter of 1518 was amended by a supplemental royal charter dated 11 March 1999. The governing instruments of the RCP are the royal charters, and the bye-laws as amended from time to time. The RCP is also registered at Companies House as a company incorporated by royal charter (no. RC000899).

Board of Trustees

The Board of Trustees is the RCP’s governing body and meets five times a year – four main quarterly meetings plus a November budget review meeting. In 2025 the Board of Trustees also held a strategy away day.

It is responsible for:

The RCP is committed to ensuring best practice governance and the Board of Trustees embeds the Charity Governance Code to ensure the organisation’s effectiveness:

> Integrity – trustees are expected to follow ‘The seven principles of public life’ drawn up by the Committee on Standards in Public Life. The RCP has embedded its Code of Conduct and organisational values within all areas of its business. A raising concerns policy is in place to support and encourage a responsive culture where people can speak up when things go wrong and the organisation can continue to learn and improve. The RCP’s anti-fraud policy was reviewed and updated in 2025, as were supporting policies such as the gifts and hospitality policy (anti-bribery). A statement relating to the Modern Slavery Act is on the RCP website.

The Board of Trustees has the authority to delegate any of its powers to the RCP’s boards and committees. Ultimately, all decisions apart from changes to the byelaws and regulations are either taken by or on behalf of the Board of Trustees and reported at the annual general meeting.

28

The Board of Trustees comprises:

There is one board that maintains close and effective links with the medical specialist societies and reports to Council:

Boards

There are four boards with specific responsibility to the Board of Trustees. They are:

Independent trustees are recruited following a rigorous selection process based on the needs of the Board in terms of expertise in areas of interest or risk to the RCP that require specialist support. All trustees are inducted in the operations of the RCP as well as their statutory obligations as a charity trustee when they are appointed. The training requirement for trustees is kept under regular review. An online governance hub makes material more accessible to trustees and an online declaration of personal interests and good standing of trustees supports good governance processes.

RCP Council

Council meets six times a year. Its function is to develop RCP policy in relation to professional and clinical matters, and to give authority to:

RCP officers

The senior officers of the RCP (president, clinical vice president, academic vice president, vice president for education and training, treasurer and registrar) all have trustee responsibilities during their tenure. The president, treasurer and registrar are trustees of the charity for the entirety of their tenure, while vice presidents are trustees on a rotational basis. Their involvement in all of the main boards and committees of the RCP ensures that due consideration is given to the RCP’s charter and bye-laws on every occasion.

Annual general meeting

The annual presidential election is held on the first Monday after Palm Sunday by Act of Parliament. The AGM was decoupled from the presidential election in 2020 and now takes place in September.

Fellows

Fellowship is the highest level of membership of the RCP and comes with many benefits and responsibilities. Fellows will be clinical leaders within their teams and will demonstrate excellence in a range of professional domains. Fellows are nominated or can be selfnominated for election with Council as final arbiter. Fellows have the right to stand for office, to vote for officers and to attend and vote at the AGM.

Finance and Resources Board

In 2025 the Finance and Resources Board met four times. It has responsibility for:

The Finance and Resources Board is chaired by the treasurer, and its membership includes the president and registrar (both ex officio), two elected members of Council, two other fellows, one independent trustee and up to four members from outside the RCP.

29

There are three committees with specific responsibility to the Finance and Resources Board. They are:

Audit and Risk Committee

In 2025 the Audit and Risk Committee met four times. It has responsibility for:

The committee is chaired by an independent trustee, and its membership includes up to two Council members and up to three independent members.

During the year the committee commissioned three internal audits by HaysMac as part of a continuing series which seeks to examine and improve various financial and operational practices of the RCP.

Remuneration Committee

This committee is chaired by an independent trustee and includes the RCP treasurer, director of finance, and an external independent adviser. Members are selected for their ability to exercise independent judgement on remuneration and governance matters.

The committee advises the Board of Trustees on pay policy, key management remuneration, and the annual pay award. It focuses on CEO and executive pay and considers wider issues such as overall pay structures, the gender pay gap, and other relevant pay-related matters. Discussions are informed by a detailed annual report from the executive director of People and Culture, supported by external benchmarking data.

A full organisational benchmarking exercise is carried out every 3 years with external experts to ensure fair and competitive pay. Recommendations are reviewed and approved by the Board of Trustees.

30

Statement of trustees’ responsibilities

The trustees are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.

Charity law requires the trustees to prepare financial statements for each financial year in accordance with Financial Reporting Standards (FRS102) and applicable law.

Under charity law the trustees must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the charity and the group and of the group’s net incoming or outgoing resources for that period. In preparing these financial statements, the trustees are required to:

The trustees are responsible for keeping adequate accounting records that are sufficient to show and explain the charity’s and the group’s transactions and

disclose with reasonable accuracy at any time the financial position of the charity and the group and enable them to ensure that the financial statements comply with the Charities Act 2011, the Charity (Accounts and Reports) Regulations 2008 and the provisions of the royal charters and bye-laws. They are also responsible for safeguarding the assets of the charity and the group, and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

The trustees of the charity are aware of their duty under section 17 of the Charities Act 2011 to have due regard to public benefit guidance published by the Charity Commission for England and Wales.

The trustees are responsible for the maintenance and integrity of the corporate and financial information included on the charity’s website. Legislation in the UK governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.

Management

Responsibility for the day-to-day operations of the RCP is delegated to the chief executive, who is accountable to the Board of Trustees. The management and staff of the RCP are structured to carry forward the work and achieve the objectives of the RCP, and to provide support services.

Key management personnel are considered to be those personnel who have the authority and responsibility for planning, directing and controlling the activities of

the RCP. Key management personnel are remunerated within the RCP’s general staff policy for pay and reward that is competitive within the charity sector, proportionate to the complexity of each role, and responsible in line with the RCP’s charitable objectives.

A large number of volunteers are involved with the RCP’s work, in the UK and abroad. The vast majority are doctors who are RCP members and support RCP activities, such as by being examiners, regional advisers or representatives on consultant appointment committees. There are many more examples, and the RCP also has a Patient and Carer Network which allows members of the public to become involved. Medical staff give their own time but also rely on NHS guidance about the ability to use NHS time for the greater benefit of the NHS.

Modern slavery statement

Pursuant to section 54(1) of the Modern Slavery Act 2015, the RCP has published a slavery and human trafficking statement on its website.

Risk management and principal risks

The trustees have overall responsibility for risk management in the RCP. The RCP follows an Enterprise Risk Management methodology for identifying and addressing methodically the potential events that represent risks to the achievement of the strategic objectives of the organisation. In doing so the RCP is guided by best practice guidelines including Charity

31

Commission’s ‘Charities and Risk Management guidance (CC26).’ The controls put in place provide a reasonable but not absolute assurance that risks have been adequately mitigated.

Risk issues in the day-to-day operations of the RCP are delegated to management to monitor and implement appropriate control measures. Any new significant areas of risk identified are reported to the Audit and Risk Committee, including how they have been managed. The Audit and Risk Committee reports any areas of concern to the trustees, with recommendations for corrective action.

The principal categories of risk that the RCP monitored and sought to mitigate in 2025 and into 2026 are:

Remedial actions to mitigate or remove these risk areas focus on:

32

Officers and key staff of the RCP

The officers, trustees and councillors listed below served during 2025. Current lists can be found via www.rcp.ac.uk/about-us/governance.

Visitor

His Majesty The King

Officers of the RCP

College officers represent the interests of our fellows and members. They provide strategic leadership and lead the way on policy development, playing an important role in representing physicians’ interests in the development of the profession and standards of healthcare.

Senior officers

President

Professor Mumtaz Patel (elected 14 April and installed 13 May; previously acting as president from 21 June 2024)

Registrar

Dr Omar Mustafa

Treasurer

Professor Simon Bowman

Clinical vice president

Dr Hilary Williams (appointed 1 August 2025) Dr John Dean (demitted 31 July 2025)

Academic vice president Professor Tom Solomon CBE

Vice president for education and training (senior censor) Professor Mumtaz Patel

College officers Vice president for Wales Dr Hilary Williams

Vice president – Global

Dr Emma Vaux OBE (appointed 1 August 2025) Dr Omar Mustafa (demitted 31 July 2025)

Linacre fellow

Dr Shruthi Konda

Harveian librarian

Professor Anita Simonds

Patient involvement officer

Dr Laura Waters (demitted 31 August 2025 – post removed)

Censors

Dr Peter Andrews Dr Anita Banerjee Dr Alexander Crowe (appointed 1 August 2025) Dr Daniel Furmedge

Dr Sarah Gladdish (appointed 1 August 2025) Dr Elaine Hui (appointed 1 August 2025) Dr Ruth Law (demitted 31 July 2025) Dr Clive Lewis Dr Rajaratnam Mathialagan (demitted 31 July 2025) Dr Jo Sykes (demitted 31 July 2025) Professor Alexander Thomson

Medical directors

Medical director of CME and CPD Professor Mumtaz Patel

Medical director of publishing Professor Anton Emmanuel (demitted 30 September 2025)

Director, medical workforce data and insights

Dr Sarah Logan (demitted 30 June 2025) Dr Stella George (appointed 1 July 2025)

Medical director for invited reviews Dr Adam De Belder

Clinical leads

Specialist, associate specialist and specialty (SAS) doctor lead Dr Naeem Aziz

Clinical director for improvement

Dr Andrew Rochford (demitted 7 March 2025, role responsibilities shared across the two roles below)

Clinical director for improvement programmes Dr Aklak Choudhury (appointed 16 June 2025)

Clinical director for patient safety and clinical standards Dr Zuzanna Sawicka (appointed 1 May 2025)

Clinical lead for digital health Dr Anne Kinderlerer

33

Editor-in-chief, Clinical Medicine Professor Ponnusamy Saravanan

Editor-in-chief, Future Healthcare Journal Dr Andrew Duncombe

Editor-in-chief, Medical Care – driving change Dr Daniel Smith

Deputy medical director for invited reviews

Dr Jonathan Bennett (demitted 30 June 2025) Dr Emma-Kate Reed

Dr Sean Weaver

Professor Nick Curzen (appointed 13 October 2025) Professor Alistair Chesser (appointed 13 October 2025)

Garden fellow Professor John Newton

International medical director, assessment

Dr Tanzeem Raza

Medical director, CPD

Dr Adrian Jennings

Medical director, workforce

Dr Phil Bright (appointed January 2026)

Associate medical director, written exams

Clinical lead for outpatients Dr Theresa Barnes

Examiners

Clinical lead for assessment Dr Celia Bielawski

Representative on the Advisory Committee of the Chelsea Physic Garden Dr Noel Snell

Officers of the Federation Executive medical director Dr Mike Jones

Professor Albert Ferro

Associate medical director, clinical exams

Dr Rod Harvey

Deputy medical director, JRCPTB

Dr Stephen Glen (appointed May 2025)

Senior examiner: RCP PACES

Dr Rasha Mukhtar

Senior examiner: Physician Associate Registration Assessment Ruth Berry

Senior examiner: Diploma in Geriatric Medicine Dr Joseph Grey (appointed February 2025) Professor Michael Vassallo (demitted January 2025)

Senior examiner: Diploma in Global Health Dr Chiara Morrison

Other senior roles

Medical director, training and development Dr David Marshall

Medical director, assessment

Dr Stuart Hood

International medical director, training and development Professor David Black (demitted December 2025) Dr Jane Wallace (appointed December 2025)

Deputy international medical director, training and development Dr Jane Wallace (appointed January 2025)

Board of Trustees

The RCP’s governing body is responsible for ensuring the RCP operates within its charitable objectives, agreeing and monitoring the RCP operational plans and ensuring the effective management and custody of all RCP assets.

Ex-officio members (senior officers)

Professor Mumtaz Patel Dr Omar Mustafa Professor Simon Bowman Professor Tom Solomon CBE

Dr Hilary Williams (appointed 1 August 2025) Dr John Dean (demitted 31 July 2025)

Deputy registrar Dr Ben Chadwick (appointed 10 March 2025)

34

Members nominated from Council

Dr Ananthakrishnan Raghuram MBE Dr Eileen Burns MBE Dr Ganesh Subramanian

Treasurer

Professor Simon Bowman

Registrar

Representative of the Faculty of Intensive Care Medicine

Dr Daniele Bryden (demitted 29 October 2025) Dr Jack Parry-Jones (appointed 30 October 2025)

Dr Omar Mustafa

Independent members

Dr Diana Walford CBE (appointed 11 March 2025) Anne Marie Millar Katie Smith Professor John Bateson Dr Fiona Pathiraja Dominic Whittle

Members of Council

Council develops RCP policy in relation to professional and clinical matters. Members hold voting rights. Other college officers and roles are in attendance at Council but do not hold voting rights.

President

Professor Mumtaz Patel (acting as president until 13 April; elected 14 April and installed 13 May 2025)

Vice president for education and training

(senior censor) Professor Mumtaz Patel

Clinical vice president

Dr Hilary Williams (appointed 1 August 2025) Dr John Dean (demitted 31 July 2025)

Academic vice president Professor Tom Solomon CBE

Vice president for Wales

Dr Hilary Williams (appointed clinical vice president from 1 August 2025)

Vice president – Global

Dr Emma Vaux OBE (appointed 1 August 2025) Dr Omar Mustafa (demitted 31 July 2025)

Representative of the Faculty of Occupational Medicine

Dr Robin Cordell

Representative of the Faculty of

Pharmaceutical Medicine Dr Sheuli Porkess

Representative of the Faculty of Public Health

Dr Tracy Daszkiewicz (appointed 30 June 2025) Professor Kevin Fenton CBE (demitted 29 June 2025)

Representative of the Faculty of Forensic and Legal Medicine Dr Alex Gorton (appointed 9 May 2025) Dr Bernadette Butler (demitted 8 May 2025)

Representative of the Royal College of Emergency Medicine

Dr Adrian Boyle (demitted 10 September 2025) Dr Ian Higginson (appointed 11 September 2025)

Representatives of the regional advisers

Dr Benjamin Chadwick (demitted 9 March 2025) Dr Jacob de Wolff (appointed 4 November 2025) Dr Stella Hughes Dr Anita Jones Dr Sam Rice

Elected councillors

Dr Eileen Burns MBE Dr Karl Davis Dr Paul Dilworth Professor Rowan Harwood Professor Nicholas Hopkinson (appointed 1 August 2025) Dr Dilesh Lakhani (appointed 1 August 2025) Dr Sarah Logan (appointed 1 August 2025) Professor Partha Kar OBE (demitted 16 July 2025) Dr Khin Swe Myint (demitted 31 July 2025) Dr Rasha Mukhtar (appointed 1 August 2025) Dr Claire Pulford Professor Koottalai Srinivasan Professor Ganesh Subramanian (demitted 31 July 2025) Dr Victoria Tippett Dr Ajay Verma (demitted 31 July 2025)

35

Representatives of the censors

Dr Daniel Furmedge (appointed 1 August 2025) Dr Anita Banerjee (appointed 1 August 2025) Dr Rajaratnam Mathialagan (demitted 31 July 2025) Dr Jo Sykes (demitted 31 July 2025)

Chair of the Patient and Carer Network

Sam Mauger

Representatives of the New Consultants Committee

Dr Katie Honney (demitted 30 September 2025) Dr James Norman (appointed 1 October 2025) Dr Aidan O’Neill (demitted 3 October 2025)

Representatives of the Resident Doctor Committee

Dr Stephen Joseph (appointed 17 September 2025) Dr Anthony Martinelli (demitted 16 September 2025) Dr Catherine Rowan

Representative of the Staff and Associate Specialists Steering Group Dr Naeem Aziz

Representatives of the specialist societies

Professor Stephanie Baldeweg Dr Sarah Cox (demitted 31 March 2025) Dr Richard Davenport (demitted 8 May 2025) Professor Jugdeep Dhesi Dr Tamara Griffiths Dr Suzanne Kite (appointed 1 April 2025) Dr Joanna Ledingham Dr Nicholas Murch (demitted 21 September 2025) Professor Ghulam Ng

Dr Victoria Price (appointed 22 September 2025) Professor Colin Rees Professor Neil Robertson (appointed 9 May 2025) Dr Richard Russell Dr Catherine Vinen

Trustee councillors (in attendance)

Dr Ananthakrishnan Raghuram MBE Dr Eileen Burns MBE Professor Ganesh Subramanian

Leadership team

The leadership team is responsible for the delivery of strategic and operational objectives.

Chief executive

Jonathan Brüün (from January 2026) Catherine Powell and Tom Baker (interim from March to December 2025) Dr Ian Bullock (until March 2025)

Executive director, Membership Support and Global Engagement Matthew Foster

Executive director, Care Quality Improvement Ian Atkinson

Executive director, Education

Tom Baker David Parry (interim from March to December 2025)

Executive director, Communications, Policy and Research Claire Burroughs

Chief executive officer – Federation

Rachael O’Flynn

Executive director, Finance

Catherine Powell David Smith (interim from March to December 2025)

Executive director, People and Culture Chiraag Panchal

36

Summary of income and expenditure

Income

Total in 2025: £46.3 million Total in 2024: £44.4 million Breakdown of income in £000s

Expenditure

Total in 2025: £45.8 million Total in 2024: £44.7 million

Breakdown of expenditure in £000s

----- Start of picture text -----
Donations, grants
0.9% £396
and legacies Costs of fundraising 1.0% £448
0.8% £349 0.9% £405
45.0% £20,864 51.1% £23,412
Educating Educating
43.3% £19,220 50.1% £22,392
12.0% £5,546 17.6% £8,065
Improving Improving
12.5% £5,557 17.0% £7,591
Influencing 21.6% £10,003 Influencing 16.7% £7,631
24.3% £10,768 18.2% £8,131
Income from 2.8% £1,305 Investment 0.1% £24
investments management fees
1.5% £648 0.2% £98
Commercial meetings, 17.7% £8,215 Commercial meetings, 13.6% £6,234
events and other income 17.6% £7,827 events and other expenditure 13.7% £6,111
----- End of picture text -----

Notes

2025

----- Start of picture text -----
2024
----- End of picture text -----

Costs of fundraising include overheads (see Note 11). Educating includes examinations, conferences, education and training, library and museum services. Improving includes audit and accreditation programmes, invited reviews and quality improvement activities. Influencing includes membership activities, publishing, policy and campaigns..

37

Financial policies

Fundraising

The RCP is grateful for the exceptional level of support that we have received during 2025 from our generous donors and sponsors, including members and fellows, charitable trusts and foundations, and corporate partners.

Philanthropic support and corporate partnerships are fundamental to the work of the RCP and help us to fulfil our charitable mission to improve patient care and reduce ill health across communities. The funds that we raise go directly to supporting research; education and training; clinical improvement; patient safety; and the maintenance and development of our buildings and historic collections. This report allows us to show how our charitable funds are distributed and spent. It demonstrates the benefits and impact of fundraising on supporting physicians and ensuring the best possible health and healthcare for everyone.

Principal fundraising activities and performance

During 2025, we secured £449k in cash income from donations and sponsorship. This was made up of £263k in donations (including legacies) and £186k in sponsorship for specific work carried out as part of our charitable objectives.

Projects supported during the year included:

Fundraising controls and regulation

The RCP’s fundraising programme is carried out by a dedicated team, including specialists in trusts and foundations, corporate, and major donor fundraising. The director of development reports to the CEO and works closely with the Board of Trustees.

38

We recognise that our fundraising success is dependent on maintaining the trust of our donors and the public. We have multiple controls in place to ensure that our fundraising remains ethical, transparent, respects vulnerable people, and is compliant with current regulation. Our campaigns are run by an in-house team, and we do not engage the services of commercial partners to raise funds on our behalf. Our Board of Trustees plays an active role in our fundraising activities and ensures that fundraising activity operates in line with regulatory requirements and relevant best practice.

We have an ethical fundraising policy and carry out due diligence to ensure that we do not receive any donations or sponsorships that conflict with our values. The RCP is registered with the Fundraising Regulator (ref 128235) and has adopted the Code of Fundraising Practice. No complaints were received in relation to our fundraising activities during 2025 (2024: nil).

Investments

Powers and governance

The RCP’s bye-laws give the trustees powers to appoint fund managers to manage its investments.

The Investment Advisory Panel (IAP) is responsible for monitoring the performance of the investment portfolios and of the fund managers. The IAP meets with the fund managers quarterly to review their reports and progress. The IAP is chaired by the treasurer, and its membership includes fellows, independent external advisers and the executive director of finance. The panel reports to the Finance and Resources Board.

Management

The majority of investments are managed by Cazenove Capital (part of Schroders plc) who have discretionary powers of investment within agreed restrictions as agreed in the Statement of Investment Principles. The managers’ mandate is to invest, on a total return’s basis, in a globally diversified portfolio of cash, equity, fixed income, convertible bonds, hedge fund securities, property funds and commodities’ funds. A relatively small

investment remains with the former (pre-2011) investment managers Morgan Stanley, in the form of hedge funds that are slowly being run down, liquidated and transferred to Cazenove. One other trust fund (The Cotton Trust) remains invested (as per its terms) with RBC / Royal Trust Corporation of Canada.

During 2025, the management of the investment portfolio has been reviewed by the Finance and Resources Board and the trustees, and our approach has been clarified with the investment managers.

The RCP’s objective is to invest its investment assets to manage returns, with a low to moderate level of risk, with targeted returns of CPI + 4% through a diversified asset portfolio. Within this framework a number of objectives have been agreed to help guide the Finance and Resources Board in their strategic management of the RCP’s investments.

Ethical and Climate Change Investment Policy

The RCP operates an Ethical Investment Policy that sets minimal tolerances on the proportion of indirect funds held linked to the production or supply of tobacco, armaments, pornography, gambling, high interest lending and sale or production of alcohol.

Climate change will significantly impact public health both in the UK and around the world. All that can be done should be done to limit global temperature rises in line with the goals of the Paris Agreement on climate change. If we are to avoid the extreme impacts of climate change on both people and the environment this means a world where we limit temperature rises to 1.5 degrees above pre-industrial levels.

As a medical college the RCP has a particular role to play in highlighting the health impact of climate change. Since December 2021 our fund managers have reported that indirect investment in fossil fuels has reduced to zero.

39

Reserves policy

The trustees consider it prudent that unrestricted reserves should be sufficient to avoid the necessity of realising fixed assets held for the charity’s use; to maintain an adequate liquidity ratio; and to cover the short-term financial impact of specific areas of risk to which the charity is currently exposed.

The actual level of reserves is monitored against this policy and reviewed by the trustees throughout the year. Funds held in reserves not needed for immediate use are invested in line with the RCP’s charitable purpose.

At 31 December 2025 the total reserves of RCP were £50.9m. The RCP holds several permanently endowed and restricted funds, which result from bequests or donations for particular purposes, details of which are set out in notes 20 and 21 to the financial statements. At 31 December 2025 total restricted funds were £2.1m and endowment funds were £13.9m.

The RCP also holds reserves in the form of designated funds that are earmarked for particular purposes by the trustees. At 31 December 2025 the balance on the designated funds was £24.9m. The main designated fund is the intangible and fixed assets fund, represented by tangible and intangible fixed assets, which is not readily converted into cash.

The general reserves of the RCP, excluding designated funds, are represented by a mixture of external investments and net assets that include cash reserves.

The general reserves of the RCP as at 31 December 2025 were £10m. Free reserves net of lease liabilities amounted to £17m and represent 4.6 months of the unrestricted operational expenditure, a significant improvement on the previous year. During 2026, the Board of Trustees has updated the RCP reserves policy to ensure that adequate reserves are set aside to manage risks. This sets a reserve target of £12.4m, which is £4.6m below our actual reserves. Given the longer-term uncertainties surrounding the Estate, the College considers this position to be appropriate.

Trading subsidiary

The principal activity of the company is to organise, provide facilities for and hold conferences, seminars, and courses of instruction, demonstrations, lectures, exhibitions, private dinners and functions. The accumulated net profit for the RCP’s wholly owned trading subsidiary, The RCP Regent’s Park Limited, for the year ended 31 December 2025 was £790k. The trading results and balance sheet of the subsidiary extracted from its audited accounts are set out in note 23 to the financial statements.

Going concern

The financial statements are prepared on a going concern basis. The Board of Trustees has considered the adoption of a going concern basis in the preparation of these financial statements. A projection of the RCP’s financial position has been undertaken, including:

 a review of budgets and 2026 management accounts

40

For the period to September 2026 the Board of Trustees has considered the strength of operational recovery, set against inflationary pressures, risks and assumptions, together with actions including income generation and cost saving measures. Working capital requirements are met through income received from business activities and the RCP can drawdown against funds held within the investment portfolio if required.

Future financial plans

The trustees remain vigilant in seeking to protect the RCP and support its members and to use the resources available to fulfil the RCP’s objectives and promote its work as efficiently as possible.

While the RCP’s balance sheet position is strong, the economic conditions facing the RCP remain challenging. The focus will be on growing our membership and keeping expenditure down while we refocus our activities in line with our new strategy launching in 2026.

Having regard to the above, the Board of Trustees believes it appropriate to adopt the going concern basis of accounting in preparing the financial statements.

41

Financial review

The RCP ended the year with a small surplus, reflecting effective cost control across the organisation. Overall, the RCP reported a 4% increase in income, attributable to increased activity and engagement from members, along with increased returns on investments.

Despite these positive developments, the RCP faced ongoing challenges related to elevated inflation throughout the year. These impacted costs associated with examination delivery, catering, energy, travel and maintenance, and were compounded by disruptions stemming from the MRCP(UK) Part 2 written examination error identified by the Federation.

Since 2023, a financial improvement plan has been implemented, delivering sustained savings across the RCP to address some of these financial pressures. The net unrestricted operating gain totalled £809k in 2025, compared to an unrestricted surplus of £377k in 2024 after adjusting for a transfer from trust funds to cover charitable activity that was funded from trust funds during the year.

Endowment income benefited from robust investment returns, which aligned with endowment expenditure and resulting in a small operating loss of £6k (2024: surplus of £141k).

Restricted expenditure surpassed restricted income in 2025, as funds were utilised to support college charitable activities. Consequently, this led to a total operating loss of £288k (2024: loss of £319k).

The year remained strong for investments, with significant gains achieved again in the financial markets. This generated an overall unrealised gain on investments of £2,345k (2024: gain of £1,827k). Additionally, an actuarial gain of £408k (2024: loss of £328k) on the closed defined benefit pension fund contributed to an overall surplus net funds movement of £3.3m (2024: gain of £1.1m).

----- Start of picture text -----
£2.5m increase in unrestricted
reserves
----- End of picture text -----

Income and expenditure

The RCP’s consolidated total income in 2025 was £46.3 million (2024: £44.4 million), representing steady growth from the previous year.

Unrestricted income increased by 4% in 2025, across the three priority areas of educating, improving and influencing. Trading income also rose significantly during the year from previous levels as event activity increased.

Investments

As of 31 December 2025, our total investments, including cash deposits, amounted to £35.7 million (2024: £29.3 million). The investment portfolio produced unrealised gains of £2,345k (2024: £1,828k). Income from

42

investments reached £1,304k (2024: £648k), resulting in an overall net return of 10.2% after fees (2024: 8.9%).

Our investment strategy aims for long-term growth at 4% above CPI inflation while maintaining an acceptable risk profile through a total return approach. Currently, most of our investments are managed by Cazenove, with minor holdings retained by Morgan Stanley and Canada Trust Corp. Thanks to Cazenove’s expertise and the guidance of our knowledgeable Investment Advisory Panel, we consistently meet our performance targets and maintain downside protection. We continue to refine our ethical investment principles to support RCP’s charitable commitment to health improvement and harm prevention. The transition to eliminate any remaining fossil fuel assets from RCP’s portfolio has now been completed.

Pensions

By the end of 2025, the defined benefit pension scheme – which has not allowed new members since 2002 and stopped accruals from 2008 – held a surplus of £910k (2024: surplus of £1,538k) according to FRS 102 standards. This change resulted from market fluctuations that reduced the value assigned to scheme assets.

In December 2025, the Board of Trustees agreed to explore a potential buyin/buy-out of the defined benefit pension scheme as part of a long-term strategy to mitigate future financial risks arising from changes in underlying assumptions.

The triennial actuarial valuation for the scheme, dated 1 January 2024 and completed at the end of June 2024, revealed a significant improvement over the deficit previously noted in 2021, reaching a funded position due to changes in assumptions and increased contributions. The next scheduled triennial valuation will occur on 1 January 2027.

contribution pension scheme, which closed to new entrants at the beginning of 2018 but remains active for current staff.

Balance sheet and reserves

At the end of 2025 the RCP held net assets of £50.9 million of which £35.7 million is the market value of our investment portfolio and £10.9 million is in cash. Endowment and restricted funds comprise £16 million, therefore unrestricted funds comprise £34.9 million, of which free reserves (net of the designated funds but gross of the long-term lease liability) have increased to £17 million.

Heritage assets (rare books, manuscripts, paintings, silverware), originally gifts to the college over the past 5 centuries, are not valued in the financial balance sheet but have an insurance value of ~£41 million.

External auditor

Crowe U.K. LLP has indicated its willingness to be reappointed as statutory auditor.

Approved by the Board

The annual report has been approved by the Board of Trustees on 24 June 2026 and signed on its behalf by:

Dr Diana Walford Chair of the Board of Trustees

Professor Simon Bowman Treasurer

The RCP continues to offer a Group Personal Pension Plan (GPPP) for new employees and manages its single-employer trust-based defined

43

Independent auditor’s report to the trustees of the Royal College of Physicians

Opinion

We have audited the financial statements of the Royal College of Physicians (‘the charity’) and its subsidiary (‘the group’) for the year ended 31 December 2025 which comprise the consolidated statement of financial activities, the parent and consolidated balance sheets, the consolidated cash flow statement and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the trustees’ use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the charity’s ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the trustees with respect to going concern are described in the relevant sections of this report.

In our opinion the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor’s responsibilities for the audit of the financial statements section of our report. We are independent of the group in accordance with the ethical requirements that are relevant to our

Other information

The trustees are responsible for the other information contained within the annual report. The other information comprises the information included in the annual report, other than the financial statements and our auditor’s report thereon. Our opinion on the financial statements does not cover the other information and we do not express any form of assurance conclusion thereon.

Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that

44

there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

Matters on which we are required to report by exception

We have nothing to report in respect of the following matters in relation to which the Charities (Accounts and Reports) Regulations 2008 require us to report to you if, in our opinion:

Responsibilities of trustees

As explained more fully in the trustees’ responsibilities statement set out on page 31, the trustees are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the trustees are responsible for assessing the group’s and the parent charity’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the trustees either intend to liquidate the charity or to cease operations, or have no realistic alternative but to do so.

Auditor’s responsibilities for the audit of the financial statements

We have been appointed as auditor under section 151 of the Charities Act 2011 and report in accordance with the Act and relevant regulations made or having effect thereunder.

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Details of the extent to which the audit was considered capable of detecting irregularities, including fraud and non-compliance with laws and regulations are set out below.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council’s website at: www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor’s report.

Extent to which the audit was considered capable of detecting irregularities, including fraud

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We identified and assessed the risks of material misstatement of the financial statements from irregularities, whether due to fraud or error, and discussed these between our audit team members, including internal specialists. We then designed and performed audit procedures responsive to those risks, including obtaining audit evidence sufficient and appropriate to provide a basis for our opinion.

45

We obtained an understanding of the legal and regulatory frameworks within which the charity and group operate, focusing on those laws and regulations that have a direct effect on the determination of material amounts and disclosures in the financial statements. The laws and regulations we considered in this context were the Charities Act 2011 together with the Charities SORP (FRS102) 2019. We assessed the required compliance with these laws and regulations as part of our audit procedures on the related financial statement items.

In addition, we considered provisions of other laws and regulations that do not have a direct effect on the financial statements but compliance with which might be fundamental to the charity’s and the group’s ability to operate or to avoid a material penalty. We also considered the opportunities and incentives that may exist within the charity and the group for fraud. The laws and regulations we considered in this context for the UK operations were employment legislation and taxation legislation.

Auditing standards limit the required audit procedures to identify noncompliance with these laws and regulations to enquiry of the Trustees and other management and inspection of regulatory and legal correspondence, if any.

We identified the greatest risk of material impact on the financial statements from irregularities, including fraud, to be within the timing of recognition of income and the override of controls by management including through significant estimates and judgements. Our audit procedures to respond to these risks included enquiries of management and the trustees about their own identification and assessment of the risks of irregularities, sample testing on the posting of journals, reviewing accounting estimates for biases, reviewing regulatory correspondence with the Charity Commission, review of internal audit reports conducted in the period and reading minutes of meetings of those charged with governance.

Owing to the inherent limitations of an audit, there is an unavoidable risk that we may not have detected some material misstatements in the financial

statements, even though we have properly planned and performed our audit in accordance with auditing standards. For example, the further removed non-compliance with laws and regulations (irregularities) is from the events and transactions reflected in the financial statements, the less likely the inherently limited procedures required by auditing standards would identify it. In addition, as with any audit, there remained a higher risk of nondetection of irregularities, as these may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal controls. We are not responsible for preventing non-compliance and cannot be expected to detect non-compliance with all laws and regulations.

Use of our report

This report is made solely to the charity’s trustees, as a body, in accordance with Part 4 of the Charities (Accounts and Reports) Regulations 2008. Our audit work has been undertaken so that we might state to the charity’s trustees those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charity and the charity’s trustees as a body, for our audit work, for this report, or for the opinions we have formed.

Crowe U.K. LLP

Statutory Auditor London

Date: 7 August 2026

Crowe U.K. LLP is eligible for appointment as auditor of the charity by virtue of its eligibility for appointment as auditor of a company under section 1212 of the Companies Act 2006.

46

Financial statements

Consolidated statement of financial activities for the year ended 31 December 2025

Notes Unrestricted
funds
Restricted
funds
Endowment
funds
Total funds Total funds
31 Dec 25 31 Dec 24
£000 £000 £000 £000 £000
Income from:
Donations, grants and legacies 2 389 7 - 396 349
Charitable activities
Educating 3 20,860 4 - 20,864 19,220
Improving 4 3,695 1,851 - 5,546 5,557
Influencing 5 9,910 93 - 10,003 10,768
Activities togenerate funds
Investment income 6 781 26 498 1,305 648
Trading activities 22 6,846 - - 6,846 6,417
Other income 7 1,369 - - 1,369 1,410
Total income 43,850 1,981 498 46,329 44,369
Expenditure on:
Raising funds
Fundraisingcosts 448 - - 448 405
Investment management fees 16 - 8 24 98
Tradingactivities 22 6,057 - - 6,057 5,941
Charitable activities
Educating 8 22,964 142 306 23,412 22,392
Improving 9 6,016 1,907 142 8,065 7,591
Influencing 10 7,363 220 48 7,631 8,131
Other 177 - 177 170
Total expenditure 11/12 43,041 2,269 504 45,814 44,728
Net operating (loss)/gain 809 (288) (6) 515 (359)
Netgains on investment assets 14 1,226 54 1,064 2,344 1,827
Net income/(expenditure) 2,035 (234) 1,058 2,859 1,468

47

Notes Unrestricted
funds
Restricted
funds
Endowment
funds
Total funds Total funds
31 Dec 25 31 Dec 24
Transfers between funds 18/19/20 58 214 (272) - -
Actuarial (losses)/gains on defined benefit pension scheme 23 408 - - 408 (328)
Net movement in funds for theyear 2,501 (20) 786 3,267 1,140
Funds brought forward at 1 Jan 2025 18/19/20 32,417 2,119 13,126 47,662 46,522
Funds carried forward at 31 December 2025 34,918 2,099 13,912 50,929 47,662

48

Consolidated and RCP balance sheets as at 31 December 2025

2025 2024
Notes Group RCP
Group
RCP
£000 £000
£000
£000
Fixed assets
Intangible assets 13a 2,025 2,025
1,274
1,274
Tangible fixed assets 13b 22,302 22,302
23,565
23,565
Investments 14 35,674 35,674
29,266
29,266
60,001 60,001
54,105
54,105
Current assets
Stocks 51 51
62
62
Debtors 15 4,012 3,527
3,643
3,234
Investment accounts 8 1
8
1
Cash 10,926 10,926
13,195
13,195
14,997 14,505
16,908
16,492
Creditors
Amounts falling due within 1year
Creditors and accrued expenses 16 (8,426) (7,934) (8,967) (8,551)
Examination and other income
received in advance 16 (8,734) (8,734) (8,471) (8,471)
(17,160) (16,668) (17,438) (17,022)
Net current liabilities (2,163) (2,163) (530) (530)
Total assets less current liabilities 57,838 57,838
53,575
53,575
Amounts falling due after 1year
Other liabilities (6,909) (6,909) (5,913) (5,913)
Net non-current liabilities (6,909) (6,909) (5,913) (5,913)

Net assets excluding pension liability 50,929 50,929
47,662
47,662

Defined benefitpension scheme liability 23 - -
-
-

Net assets including pension liability 21 50,929 50,929
47,662
47,662

49

2025 2024
Notes Group RCP Group RCP
Represented by
Unrestricted funds:
Designated funds 18
Fixed and Intangible Assets Fund 24,327 24,327
24,840
24,840
Legacies Development Fund 160 160
120
120
Care QualityImprovement 18 18
18
18
Maintenance Fund 320 320
240
240
JAG Fund 125 125
205
205
24,950 24,950
25,423
25,423

General charitable fund 9,968 9,968
6,994
6,994
Less: Pension scheme liabilities 23 - -
-
-
9,968 9,968
6,994
6,994

Total unrestricted 34,918 34,918
32,417
32,417
Restricted 19 2,099 2,099
2,119
2,119
Endowment 20 13,912 13,912
13,126
13,126
50,929 50,929
47,662
47,662

The results of the parent charity for the year ended 31 December 2025 was a £3,267k surplus (2024: £1,140k surplus).

Approved for and on behalf of the RCP (Charity Registration No 210508) on 24 June 2026 and authorised for issue.

President: Professor Mumtaz Patel

Treasurer: Professor Simon Bowman

50

Consolidated statement of cash flow for the year ended 31 December 2025

2025
£000
2024
£000
5,055
648
(1,272)
(490)
111
-
(1,003)
-
(174)
(174)
3,878
9,325
13,203
2025
Cash flow from operating activities
Net cashprovided by / (used in)operatingactivities A 2,848
Dividends,interest and rents from investments 1,182
Purchase ofproperty, plant and equipment (1,178)
Purchase of intangible assets (918)
Proceeds from sale of investments -
Purchase of investments (4,063)
Net cashprovided by (used in) investing activities (4,977)
Borrowings interest andprincipal repayments -
Finance leasepayments (140)
Net cashprovided by (used in) financing activities (140)
Change in cash and cash equivalents in the reporting period (2,269)
Cash and cash equivalents at the beginningof the reporting period B 13,203
Cash and cash equivalents at the end of the reporting period B 10,934
Notes to consolidated statement of cash flow for the year ended 31 December
2025
£000
2024
£000
A. Reconciliation of net income/(expenditure) to net cash flow from operating activities
Net movement in funds for the reporting period(asper the statement of financial activities) 2,859 1,468
Adjustments for:
Depreciation charges 2,441 2,353
Amortisation charges 167 232
Disposal and impairment of assets - -
Loss/(gains)on investments (2,344) (1,828)
Increase/(decrease)inprovisions - -
Dividends,interest and rents from investments (1,182) (648)
Gain on valuation of defined benefitpension scheme 408 (328)
(Increase)/decrease in stocks 11 (6)
(Increase)/decrease in debtors (369) 230
Increase/(decrease)in creditors 857 3,582
Net cashprovided by/(used in) operating activities 2,848 5,055

Notes to consolidated statement of cash flow for the year ended 31 December 2025

51

2025 2024
£000 £000
B. Analysis of cash and cash equivalents
Cash in hand 10,926 13,195
Notice deposits and investment accounts(less than 30 days) 8 8
Total cash and cash equivalents 10,934 13,203
Analysis of changes in net debt
At 1 Jan 2025 Cash flow New finance
leases
Acquired debt Interest and non-
utilisation charges
At 31 Dec 2025
£000 £000 £000 £000 £000 £000
Cash and cash equivalents
Cash in hand 13,195 (2,269) - - - 10,926
Notice deposits and investment accounts (less than
30 days)
8 - - - - 8
Total cash and cash equivalents 13,203 (2,269) - - - 10,934
**Borrowings **
Loan to finance fixed assets – falling due after
more than oneyear*
- - - - - -
Finance lease obligations (206) 140 - - - (66)
**Total borrowings ** (206) 140 - - - (66)
Total net debt 12,997 (2,129) - - - 10,868

52

Notes to the financial statements

1 Accounting policies

Charity information

The Royal College of Physicians (RCP) was established by royal charter in 1518. It is registered with the Charity Commission for England and Wales and is a Royal Charter company registered with Companies House. The charity registration number is 210508 and the company registration number is RC000899. The RCP is a public benefit entity and its registered office is 11 St Andrews Place, London NW1 4LE.

Basis of preparation

The consolidated financial statements comprise the financial statements of RCP, and its subsidiary undertaking, The RCP Regent’s Park Limited, on a lineby-line basis and adjusted for the elimination of inter-group transactions and balances.

The financial statements have been prepared in accordance with the Statement of Recommended Practice: Accounting and Reporting by Charities (2015) preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Charities Act 2011.

The RCP constitutes a public benefit entity as defined by FRS 102. The financial statements are drawn up on the historical accounting basis, except that investments held as fixed assets are carried at market value.

Going concern

The financial statements are prepared on a going concern basis. The Board of Trustees has considered the adoption of a going concern basis in the

preparation of these financial statements. A projection of the RCP’s financial position has been undertaken, including:

For the period to September 2027 the Board of Trustees has considered the strength of operational recovery, set against inflationary pressures, risks and assumptions, together with actions including income generation and cost saving measures. Working capital requirements are met through income received from business activities and the RCP can drawdown against funds held within the investment portfolio if required. The Board has agreed a financial strategy for the period 2025 to 2028 that demonstrates that the RCP has adequate levels of cash and reserves going forward.

Having regard to the above the Board of Trustees believes it appropriate to adopt the going concern basis of accounting in preparing the financial statements.

Income

Subscriptions income, admission fees, grants and donations are accounted for once there is entitlement, probability of receipt and it can be reliably measured. Legacies are accounted for where there is entitlement, probability of receipt and the amount can be measured. For residuary legacies, entitlement is deemed to be the earlier of settled estate accounts or notification of a pending payment or actual payment being received. For pecuniary legacies, these are recognised on confirmation that probate has been obtained. Investment income is recognised when due, except for dividends, which are accounted for on receipt. Income is deferred only when conditions have to be fulfilled before the RCP becomes entitled to it or where the donor has specified that the income is to be expended in the future period. In the case of examination admissions, any receipt in respect of future years is shown as deferred income. Membership fees are seen as

53

an annual subscription and recognised in the year they are due. Any membership fees received in advance are shown as deferred income. Government grants are recognised as income when any specific conditions are met.

Expenditure

All expenditure is accounted for under the accruals concept and stated gross of irrecoverable VAT. All costs are allocated to the charitable cost centres on an actual basis, with the exception of administration costs which are allocated on the following basis:

allocated to the departments within the RCP on the basis of area occupied. No depreciation or amortisation is charged on assets in the course of construction. At each reporting date the RCP assesses if there is any indication of impairment of its estate and other fixed assets.

Collections

In addition to the capitalised fixed assets held for the RCP’s own use, the RCP also has a number of assets of historical interest. These comprise learned publications and a unique collection of busts and portraits, together with other objects, whose intrinsic value is also bound up with the RCP’s history. The trustees consider that the significant administrative expenses incurred in deriving a reliable cost for the capitalisation of these items would exceed the usefulness of such information to the user of the financial statements.

Salaries are allocated according to the nature of work performed by each member of staff. Governance costs comprise the costs incurred, which are directly attributable to the management of the charity’s assets, organisational procedures and the necessary legal procedures for compliance with statutory requirements. Rentals for leased assets held under the terms of operating leases are charged directly to the statement of financial activities (SOFA) over the term of the lease.

Finance leases

Finance leases are recognised where the risks and rewards of ownership of the leased asset are held by the lessee (the RCP). These are recognised as right-to-use fixed assets with a corresponding lease liability comprised of the present value of the minimum lease payments, derived by discounting them at the interest rate implicit in the lease. Right-to-use assets are depreciated over the lease period or asset life, where the asset is retained at the end of lease and has an asset life longer that the lease term.

Investments

Tangible and intangible fixed assets

No 11 St Andrews Place, a leasehold property held under a 99-year lease expiring in 2060 and Nos 1–10 St Andrews Place, leasehold properties held under a lease that expires in 2084, are being depreciated over 49 years from the commencement of the respective leases. The cost of additions to existing structures has been depreciated, concurrently, over the remaining life of the leases. Equipment, intangible assets, furniture and fixtures are capitalised when the cost of the project exceeds £15,000 and has a useful life spread over a number of financial years. These capital costs are depreciated, and intangible assets amortised by equal instalments over their anticipated useful lives, at rates between 5% and 25%. Depreciation and amortisation is

Investments are stated in the balance sheet at the mid-market value at the balance sheet date with the exception of private equity assets, which are held at fair value and valued by the underlying manager (Schroders Capital) in line with industry guidance and regulation. Realised gains or losses are calculated by reference to disposal proceeds and either opening market value or cost if acquired during the year.

Stock

Stock is valued at the lower of cost and net realisable value.

54

Cash and cash equivalents

Cash and cash equivalents includes cash at bank and in hand, cash held for reinvestment and short-term deposits.

Taxation

The RCP is eligible for the tax exemptions available for charitable activities.

Unrestricted funds

These funds are received and applied to achieve the general objectives of the RCP.

Designated funds

Designated funds are unrestricted funds set aside by the trustees for specific future purposes or projects. The movements on these funds are analysed in note 18.

Restricted funds

Restricted funds are subject to specific conditions laid down by the donors as to how they may be used. Note 19 gives details of these funds.

Endowment funds

Endowment funds relate to bequests and gifts to the RCP, the terms of which stipulate that the capital may not be spent, and the income is to be utilised to meet the costs of awards, lectures and other RCP expenditure. Movements in these funds are shown in note 20.

Upon receiving the requisite order from the Charity Commission on 6 February 2012 the RCP trust fund committee approved the base date for the commencement of the total return investment policy to be 30 September 1988. The permanent endowments in note 20 of the financial statements have been recalculated as at the above date.

Critical accounting judgements and key sources of estimation uncertainty

The key sources of estimation uncertainty that have a significant effect on the amounts recognised in the financial statements are described in the accounting policies and are summarised below:

Pension liabilities

The charity recognises its liability to its defined benefit pension scheme which involves a number of estimations as disclosed in note 23.

Financial instruments

Financial assets and financial liabilities are recognised when the RCP becomes a party to the contractual provisions of the instrument. Additionally, all financial assets and liabilities are classified according to the substance of the contractual arrangements entered into. Financial assets and liabilities are initially measured at transaction price (including transaction costs) and are subsequently re-measured where applicable at amortised cost. Financial assets held at amortised cost comprise cash at bank and in hand, short-term investments together with accrued interest and other debtors. Financial liabilities held at amortised costs comprise other creditors and accruals.

Total return accounting

The trustees of the RCP applied to the Charity Commission in January 2012 for authorisation to enable the permanent endowments within the RCP trust funds to be invested on a total return basis as this would facilitate a better return on investments, without prejudicing the investment management policy.

Operating leases

Rental income from operating leases is recognised on a straight-line basis over the term of the relevant lease. Initial direct costs incurred in negotiating and arranging an operating lease are added to the carrying amount of the leased asset and recognised on a straight-line basis over the lease term.

55

Incoming resources

Unrestricted
Restricted/ endowment
2025
2024
Unrestricted
Restricted/ endowment
2025
2024
£000
£000
£000
£000
2
Donations, grants and legacies
Donations 198
6
204
275
Grants -
-
-
-
Legacies 191
1
192
74
389
7
396
349
3
Educating
Examinations 14,867
-
14,867
13,322
Education and training 4,108
-
4,108
4,196
Conferences 1,822
-
1,822
1,649
Libraryand museum 63
4
67
53
20,860
4
20,864
19,220
4
Improving
Accreditationprogrammes 2,738
20
2,758
2,802
National audits 48
1,796
1,844
1,796
Qualityimprovementprogrammes 375
35
410
433
Invited reviews 534
-
534
526
3,695
1,851
5,546
5,557
5
Influencing
Subscriptions 9,072
-
9,072
9,695
Journals andpublications 43
-
43
36
Media, policyand campaigns 75
93
168
189
Member conferences and events 720
-
720
848
9,910
93
10,003
10,768
6
Investment income
Dividends 251
38
289
283
Interest on investments 407
486
893
337
Bank interest 123
-
123
28
781
524
1,305
648
7
Other income
Rental income 1,159
-
1,159
1,169
Café sales 197
-
197
179
Other 13
-
13
62
1,369
-
1,369
1,410

56

Resources expended

Unrestricted Restricted/endowment 2025 2024
£000 £000 £000 £000
8 Educating
Examination services 11,312 - 11,312 10,575
Conferences 5,146 211 5,357 5,074
Education and training 5,262 233 5,495 5,571
Libraryand museum services 1,244 4 1,248 1,172
22,964 448 23,412 22,392
9 Improving
Accreditation 4,293 28 4,321 3,850
National audits 40 1,758 1,798 1,734
Qualityimprovement 936 211 1,147 1,164
Invited reviews 747 - 747 733
Awards,fellowships and bursaries - 52 52 110
6,016 2,049 8,065 7,591
10 Influencing
Membershipservices 1,664 - 1,664 1,852
Journals andpublications 1,533 - 1,533 1,502
Media, policyand campaigns 1,590 204 1,794 2,255
Member conferences and events 712 20 732 903
Committees 1,191 - 1,191 980
International networks 673 44 717 639
7,363 268 7,631 8,131

57

11 Expenditure on Direct costs Staff costs Other support costs Total 2025 Total 2024
£000 £000 £000 £000 £000
Raising funds
Fundraisingcosts 20 216 212 448 405
Investment management fees 24 - - 24 98
Tradingactivities 6,057 - - 6,057 5,941
Charitable expenditure
Educating 6,665 7,897 8,850 23,412 22,392
Improving 2,120 2,862 3,083 8,065 7,591
Influencing 1,412 2,984 3,235 7,631 8,131
Other expenditure 177 - - 177 170
Total for 2025 16,475 13,959 15,380 45,814 44,728
Total for 2024 16,282 13,253 15,193 44,728
2025 2024
The analysis of other support costs is as follows: £000 £000
Propertyservices 7,143 7,023
Information technologycosts 2,719 2,819
Audio visual 413 454
Human resources 1,040 1,018
Finance 1,288 1,272
Internal events 710 482
Governance costs* 274 279
Central 1,793 1,846
15,380 15,193

*Governance costs include fees payable to the auditors from audit fees of £59.6k (2024: £57.6k) and non-audit services of £4.4k (2024: £8.7k).

58

12 Employees and trustees Employees and trustees Employees and trustees 2025 2024
The total costs of salaries and wages were as follows: £000 £000
Salaries and wages 17,173 16,744
Social securitycosts 2,012 1,755
Pension costs 1,441 1,412
20,626 19,911
2025 2024 Restated
The average number of employees in theyear was: 431 430
The number of employees whose emoluments exceeded £60,000 were:
£60,001–£70,000 22 20
£70,001–£80,000 7 10
£80,001–£90,000 4 5
£90,001–£100,000 2 1
£100,001–£110,000 4 4
£110,001–£120,000 1 2
£120,001–£130,000 1 1
£130,001–£140,000 2 -
£140,001–£150,000 - -
£150,001–£160,000 - -
£160,001–£170,000 - -
£170,001–£180,000 - 1
2025 2024
12a Keymanagementpersonnel £000 £000
Total employee benefitspaid to keymanagementpersonnel(Including pension contributions) 1,360 1,397
12b Terminationpayments* 2025 2024
No ofpayments 17 3
Value ofpayments(£000) 254 12
12c Payments to trustees** 2025 2024
Number of payments made to trustees, this includes payments to officers supporting their defined roles as senior
officers, which may involve overseas travel as well as their trustee roles. No other remuneration was paid to trustees
from the RCP in the current orpreceding years.
10 12
Value ofpayments(£000) 27 19

*12 payments outstanding at year-end totalling £137k (2024:0).

**Trustees are not remunerated and this is a reimbursement of costs.

59

13a Intangible IT assets (Group and RCP) Intangible IT assets in use
Intangible IT assets under construction

Total 2025
£000 £000 £000
Cost at 1 January 2025 5,520 781 6,301
Additions 7 911 918
Transfers/adjustments - - -
Disposals - - -
Cost at 31 December 2025 5,527 1,692 7,219
Accumulated amortisation at 1 January 2025 (5,027) - (5,027)
Amortisation for theyear (167) - (167)
Disposals - - -
Accumulated amortisation at 31 December 2025 (5,194) - (5,194)
Net book value at 31 December 2025 333 1,692 2,025
Net book value at 31 December 2024 493 781 1,274
13b Tangible assets (Group and RCP) Leasehold
properties
Furniture and fixtures
IT & AV tangible assets
Assets under construction
Total 2025
£000
£000
£000
£000
£000
Cost at 1 January 2025 38,840
3,327
6,182
12
48,361
Additions 649
234
295
-
1,178
Transfers/adjustments 12
-
-
(12)
-
Disposals -
-
(405)
-
(405)
Cost at 31 December 2025 39,501
3,561
6,072
-
49,134
Accumulated depreciation at 1 January 2025 (19,180)
(1,490)
(4,126)
-
(24,796)
Depreciation for theyear (1,470)
(283)
(688)
-
(2,441)
Disposals -
-
405
-
405
Accumulated depreciation at 31 December 2025 (20,650)
(1,773)
(4,409)
-
(26,832)
Net book value at 31 December 2025 18,851
1,788
1,663
-
22,302
Net book value at 31 December 2024 19,660
1,837
2,056
12
23,565

60

14 Investments (Group and RCP) Unrestricted Total
Designated for leasehold General Restricted Endowment 2025
2024
£000 £000 £000 £000 £000
£000
Market value at 1 January 2025 43 15,709 1,644 11,870 29,266
27,550
Additions at cost - 4,000 - - 4,000
-
Income retained inportfolio - 95 - 6 101
Disposals - - - - -
-
Management fees - (25) - (13) (38)
(111)
Unrealised(Loss)/gains (3) 1,230 54 1,064
2,345
1,827
Total investments at 31 December 2025 40 21,009 1,698 12,927 35,674
29,266
Historical cost at 31 December 2025 14,578 647 12,683 27,908
27,036
The above investments are held as follows: 2025
2024
£000
£000
Equities 21,820
18,183
Bonds 2,702
2,542
Multi-asset funds 112
104
Alternatives 4,612
5,734
Cash 6,428
2,703
Unlisted investment commitments to be made – 2025: £956k (2024: £0)
15
Debtors (Group and RCP)
2025 2025 2024 2024
Group RCP Group RCP
£000 £000 £000 £000
Current
Trade debtors 1,505 1,020 1,089 892
Other debtors 270 270 79 79
Prepayments 1,784 1,784 1,654 1,654
Accrued income 453 453 821 609
Non-current
4,012 3,527 3,643 3,234

61

16 Creditors and accrued expenses (Group and RCP)
2025
2024
Group
RCP
Group
RCP
£000
£000
£000
£000
Current
Trade creditors
946
898
1,499
1,478
Other creditors
2,021
765
2,424
1,342
Tax and social securitycreditors
890
890
733
733
Accruals
4,502
3,676
4,164
3,203
Obligations under finance lease
67
67
147
147
Amounts due to subsidiary
-
1,638
-
1,648
8,426
7,934
8,967
8,551
Examination and other income received in advance (Group and RCP)
Balance b/f
1 Jan 25
Released to
SOFA
Received in
year
Balance c/f
31 Dec 25
£000
£000
£000
£000
Examination income
5,951
(5,951)
6,222
6,222
Other income
2,520
(2,698)
2,690
2,512
8,471
(8,649)
8,912
8,734
Non-current
Group
RCP
Group
RCP
£000
£000
£000
£000
Accruals
6,909
6,909
5,855
5,854
Obligations under finance lease
-
-
58
58
6,909
6,909
5,913
5,913
17 Financial assets and liabilities
2025
2024
£000
£000
Financial assets held at fair value
35,674
29,266
Gains/(losses)on assets held at fair value
2,345
1,827

62

18 Unrestricted funds 18 Unrestricted funds
Balance as at
01/01/2025
Income
Expenditure
Gains/losses
Transfers
Balance as at
31/12/2025
£000
£000
£000
£000
£000
£000
Unrestrictedgeneral
6,994
43,850
(43,041)
1,634
531
9,968
Unrestricted designated
Fixed and Intangible Assets Fund
24,840
-
-
-
(513)
24,327
Legacies Development Fund
120
-
-
-
40
160
Care QualityImprovement
18
-
-
-
-
18
Maintenance Fund
240
-
-
-
80
320
JAG Fund
205
-
-
-
(80)
125
32,417
43,850
(43,041)
1,634
58
34,918

Fixed and Intangible Assets Fund – this represents the amounts set aside from the general fund to fund the net book value of the RCP’s fixed and intangible asse ts. Legacies Development Fund – the fund will be utilised for appropriate and relevant projects for such purposes that the major donors can be recognised and remembered. Care Quality Improvement – funds remaining on completed projects have been designated with the aim of expanding the work carried out by this department. Maintenance Fund – the fund is designated for the quinquennial external building renovations for leased property in London. JAG Fund – the fund is designated for amounts ringfenced for future spend on the Joint Advisory Group.

63

19 Restricted funds Balance at Income
Expenses
Gains/(losses)
Transfers
Balance at
01/01/2025 31/12/2025
£000 £000
£000
£000
£000
£000
DorothyWhitneyWood – Physicians’ Fund 361 -
(5)
-
-
356
National RespiratoryAudit Programme 42 1,024
(1,009)
-
-
57
Falls and FragilityFracture Audit Programme 16 743
(736)
-
-
23
Falls and FragilityFracture Audit Programme – UCB - 30
(12)
-
-
18
Physicians’ Fund 34 -
-
-
-
34
Advanced clinicalpractice curricula development 71 -
(70)
-
-
1
The Saltwell Will Trust Research Branch 222 -
-
-
55
277
Research courseproject 20 -
(20)
-
-
-
Harold Thomas Barten Trust 133 5
-
11
-
149
Dr Everley-Jones legacy 110 4
(77)
9
-
46
External Affairs – Alcoholproject 63 93
(127)
-
-
29
Medical Care - 35
(35)
-
-
-
Sustainabilityfellow 60 -
(22)
-
-
38
PulmonaryRehabilitation Services Accreditation Scheme
28
-
(22)
-
-
6
Catherine Mills Bequest 85 3
(45)
7
-
50
Thomas Cotton Trust 87 -
-
-
3
90
Frank Peacock Bequest 81 3
-
6
-
90
QIPS –patientpartners/medication safety 22 -
-
-
-
22
Queenie Louisa Higgins Bequest 49 2
-
4
-
55
Drabu MTIprogramme 7 -
(39)
-
156
124
Mackenzie-Mackinnon Streatfield 40 1
-
3
-
44
Fundraising 35 -
-
-
-
35
Symons collection 34 -
-
-
-
34
Will Edmonds Clinical Research Trust 91 -
-
-
24
115
FundraisingHeritage Museum 34 -
-
-
-
34
The London Fever Hospital Fund 32 -
-
-
9
41
28 other funds balances below £30,000 362 38
(50)
14
(33)
331
Total 2,119 1,981
(2,269)
54
214
2,099

64

Funds with closing balances over £100k are as follows:

65

20 Endowment funds
Unapplied
total return
01/01/2025
Income
Gains/(losses)
Conversion
to income
Transfers
Unapplied total
return
‘Frozen’
permanent
capital
Total
endowment
31/12/2025
31/12/2025
31/12/2025
£000
£000
£000
£000
£000
£000
£000
£000
Bradshaw Trust
238
14
30
(28)
-
254
143
397
Eden Fellowshipin Paediatrics
1,423
58
124
(1)
-
1,604
142
1,746
John Rosser Scholarship
47
3
7
-
-
57
42
99
Joseph Senior White Trust
167
12
26
(143)
-
62
161
223
Lewis Thomas Gibbon Jenkins-Briton Ferry
1,912
118
251
(171)
-
2,110
1,250
3,360
ORL Wilson Bequest
143
7
15
-
-
165
44
209
James Maxwell Grant Prophit Bequest
576
42
89
(16)
-
691
539
1,230
Sadleir Trust
417
19
41
(43)
-
434
91
525
Samuel Leonard Simpson Fellowship
831
41
88
(1)
-
959
280
1,239
TK Stubbins Bequest
29
5
11
-
-
45
104
149
Watson Smith Trust
496
34
77
(90)
-
517
470
987
William WitheringPrize
178
8
17
-
-
203
38
241
Dr JD RamsayScholarship
64
4
8
-
-
76
30
106
Graham Bull Prize
69
2
7
(2)
-
76
25
101
Sir Michael Perrin Lecture
98
3
9
(6)
-
104
12
116
LadyTeale Lecture
11
2
5
-
-
18
44
62
John Glyn
136
8
17
(1)
-
160
80
240
Dame Sheila Kift Bequest
54
3
7
-
-
64
38
102
John Thornton Ingram Lecture
42
2
2
-
-
46
6
52
Lockyer Lectureshipand Fellowship
37
2
4
-
-
43
12
55
Simms Bequest
32
2
4
-
-
38
16
54
Professor PF Thomas Bequest
38
2
5
-
-
45
25
70
10 other funds with balances below £40,000
79
10
11
-
(19)
81
44
125
Subtotal
7,117
401
855
(502)
(19)
7,852
3,636
11,488

66

Funds not included in total return Balance at
01/01/2025
Income Gains/(losses) Conversion to
income
Transfers ‘Frozen’
permanent
capital
Balance at
31/12/2025
£000 £000 £000 £000 £000 £000 £000
Thomas Cotton Fund 207 3 9 - (3) - 216
The London Fever Hospital Research Fund 203 9 19 - (9) - 222
Saltwell Will Trust Research Branch 1,255 55 117 (1) (55) - 1,371
Will Edmonds Clinical Research Fund 563 24 52 - (24) - 615
Drabu Fund 139 6 12 (1) (156) - -
Subtotal 2,367 97 209 (2) (247) - 2,424
Total endowment 9,484 498 1,064 (504) (266) 3,636 13,912

The RCP received a total return order from the Charity Commission, dated 6 February 2012, which enables the trustees to decide which part of the unapplied total return from the investment of the charity’s permanent endowments should be held on trust for application for the purposes of the charity.

Funds with closing balances over £300k are as follows:

67

21 Analysis of group net assets after pension scheme liability 21 Analysis of group net assets after pension scheme liability 21 Analysis of group net assets after pension scheme liability 21 Analysis of group net assets after pension scheme liability 21 Analysis of group net assets after pension scheme liability
Intangible and tangible
assets
Investments Net liabilities inc
pension liability
Total
2025
Total
2024
£000 £000 £000 £000 £000
Unrestricted:
Designated Fixed Assets Fund 24,327 - - 24,327 24,840
Legacies Development Fund - - 160 160 120
CareQualityImprovement - - 18 18 18
Maintenance Fund - - 320 320 240
JAG Fund - - 125 125 205
24,327 - 623 24,950 25,423
General funds - 21,049 (11,081) 9,968 6,994
24,327 21,049 (10,458) 34,918 32,417
Restricted - 1,698 401 2,099 2,119
Endowment - 12,927 985 13,912 13,126
Total 24,327 35,674 (9,072) 50,929 47,662

68

22 Trading subsidiary – The RCP Regent’s Park Limited

The trading results and balance sheet of the RCP subsidiary company as extracted from its audited accounts are set out below.

2025
2024
restated
2025
2024
restated
2025
2024
restated
Profit and loss account £000
£000
Turnover 6,846
6,417
Cost of sales (2,847)
(2,615)
Grossprofit 3,999
3,802
Administrative expenses (3,210)
(3,326)
Operating profit/(loss) 789
476
Gift aid to Royal College of Physicians
(789)
(476)
Retainedprofit/(loss) for the financialyear
-
-

Included within administrative expenses is £3,089k (2024: £3,207k), which represents a reimbursement in respect of costs incurred by the RCP.

2025
2024
2025
2024
2025
2024
Balance sheet £000
£000
Debtors 2,122
2,057
Balance at bank 7
7
Current and total assets 2,129
2,064
Creditors due within 1year: (2,129)
(2,064)
Creditors due more than 1year: -
-
Creditor – due to RCP -
-
Total creditors (2,129)
(2,064)
Net assets -
-
Capital and reserves
Accumulated deficit -
-
Called upshare capital £1
£1
Shareholders’ funds £1
£1

The RCP’s wholly owned trading subsidiary, The RCP Regent’s Park Limited, was incorporated on 17 September 2001, company registration 04288664.

The operating profit for the year ended 31 December 2025 was £789k (2024: £476k).

The principal activity of the company is to organise, provide facilities for and hold conferences, seminars, and courses of instruction, demonstrations, lectures, exhibitions, private dinners and functions.

69

23 Pension schemes

The RCP has three pension schemes, one providing defined benefits based on final salary, the other two providing benefits based on defined contributions invested with Standard Life and Aon. The pension costs for the defined contribution scheme are charged to the statement of financial activities as they become payable in accordance with FRS 102. The pension costs relating to the defined benefit scheme are assessed in accordance with the advice of an independent qualified actuary.

The defined benefit pension scheme current service costs and the net of the scheme interest cost and the expected return on the scheme assets for the year are charged to the statement of financial activities within superannuation costs. Actuarial gains and losses are recognised within other recognised gains and losses.

Total pension costs charged for the year was net expense £408k (net expense 2024: £337k) for the defined benefit pension scheme and employer pension contributions of £1,441k (2024: £1,412k) for the defined contribution pension scheme.

One of the defined contribution schemes closed to new members in 2018 – employer contribution rates for this defined contribution scheme are determined by the members’ age bands with incremental rates for older members. The new scheme opened for new membership has a flat employer contribution rate of 7%.

The defined benefit pension scheme is closed to new members and closed to future accrual. There is no further salary linkage. For the purposes of FRS 102 the valuation of the defined benefit scheme has been calculated under FRS 102 as at 31 December 2025 by a qualified actuary. The scheme assets are measured at fair value at the balance sheet date. Scheme liabilities are measured on an actuarial basis at the balance sheet date using the projected unit method and discounted at a rate equivalent to the current rate of return on a high-quality corporate bond of equivalent term to the scheme liabilities. The resulting defined benefit asset or liability is presented separately after other net assets on the face of the balance sheet.

The valuation, details of which are given below, shows £15.54 million of assets and £14.63 million of liabilities, resulting in a scheme surplus of £910k. However, in accordance with paragraph 28.22 of FRS 102 the net pension asset has been restricted to the value of the scheme’s future pension cost less future employee contributions. The net pension asset therefore becomes £nil.

The scheme’s assets and liabilities as at 31 December 2025, analysis of pension costs and details of the valuation were as follows:

Principal assumptions 2025 2024 2023 2022
2021
%per annum %per annum %per annum %per annum
%per annum
Discount rate 5.40 5.45 4.55 4.80
1.85
Aggregate long-term expected rate of return on assets 5.40 5.45 4.55 4.80
1.85
Rate of increase of salaries n/a n/a n/a n/a
n/a
RPI inflation assumption forpensions inpayment 2.75 3.05 2.95 3.00
3.25
CPI inflation assumption for deferredpensions 2.00 2.50 2.40 2.45
2.65
Pension increases
-
RPI min 0%,max 5%(p.a.)
2.75 3.00 2.90 2.95
3.15
-
RPI min 2.5%,max 5%(p.a.)
3.15 3.35 - -
-
Pension commencement lump sum taken at retirement 18.75% of benefit
value
18.75% of benefit
value
18.75% of benefit
value
18.75% of benefit
value


18.75% of benefit
value

70

Mortality tables: 101% of S3PMA tables for men and 94% of S3PFA tables for women using CMI 2024 model with a 1.25% long-term rate of improvement based on year of birth.

The assets valued below are in the form of monies invested with Legal and General Investment Management, BMO Global Asset Management, M&G Investments and Janus Henderson Investors together with the trustees’ bank account. The assets in the scheme and the expected rate of return were:

Assets breakdown 2025 2024
% %
Real return and absolute return funds - -
UK Government index-linkedgilts 67.30 63.99
Multi asset credit 17.39 20.06
UK corporate bonds 10.13 9.79
Equities 4.31 5.53
Cash 0.87 0.63
Total market value of assets 100 100

The pension scheme has not invested in any of Royal College of Physicians’ own financial instruments, nor in properties or other assets used by the Royal College of Physicians. The assets are all quoted in an active market.

Movement in deficit during the year Movement in deficit during the year 2025 2024
£000 £000
Pension scheme liabilityat the beginningof theyear - -
Employer contributions - 665
Income/(expense)recognised inprofit and loss (408) (337)
Remeasurementgain/(loss)recognised in OCI 408 (328)
- -
2025 2024
£000 £000
Present value of scheme liabilities at beginningof theyear 14,710 16,225
Past service cost - 145
Interest cost 781 724
Actuarial(loss)/gain on scheme liabilityassumption changes (103) (1,748)
Benefitspaid (754) (636)
Present value of scheme liabilities at the end of theyear 14,634 14,710
£000 £000
Fair value of scheme assets at beginningof theyear 16,248 17,051
Interest income 855 779
Return on scheme assets (407) (1,402)

71

Movement in deficit during the year 2025 2024
Employer contributions - 665
Benefitspaid (754) (636)
Administration expenses (398) (209)
Fair value of scheme assets at the end of theyear 15,544 16,248
2025 2024
£000 £000
Fair value of scheme assets 15,544 16,248
Value of liabilities(defined benefit obligation) (14,634) (14,710)
Funded status 910 1,538
Adjustment in accordance with the limit in FRS 102
paragraph 28.22
(910) (1,538)
Recognisedpension scheme liability - -
Analysis of pension scheme assets and liabilities for the current and previous five financial periods 2025 2024 2023 2022 2021 2020
£000 £000 £000 £000 £000 £000
Present value of scheme liability (14,634) (14,710) (16,225) (15,445) (22,342) (24,526)
Fair value of scheme assets 15,544 16,248 17,051 16,082 21,956 20,287
Surplus/(Deficit) 910 1,538 826 637 (386) (4,239)
Adjustment in accordance with the limit in FRS 102paragraph 28.22 (910) (1,538) (826) (637) - -
Surplus/(Deficit) - - - - (386) (4,239)

At the date of the last triennial statutory actuarial assessment as at 1 January 2024, the market value of the scheme was £18.57 million and the actuarial value of those assets represented 100.4% of the value of the benefits which had accrued at that date, allowing for future pension increases.

72

24 Lease obligations 2025 2024
£000 £000
Operating leases on land and buildings, by expiry date:
Under 1year 7 18
1 to 5years 5,237 3,709
5yearsplus 22,325 23,861
Total future minimum operating lease commitments 27,569 27,588
Operating leases on office equipment and computers, by expiry date:
Under 1year 64 90
1 to 5years 143 111
5yearsplus 6 -
Total future minimum operating lease commitments 213 201
Finance leases on IT equipment, by expiry date:
Under 1year - 22
1 to 5years - -
5yearsplus - -
Total future finance lease commitments - 22
Finance leases on land and buildings, by expiry date:
Under 1year 67 125
1 to 5years - 58
5yearsplus - -
Total future minimum finance lease commitments 67 183

In August 2019 the RCP signed an agreement for lease for 69,890 square feet over seven floors of ‘The Spine’ with Liverpool City Council for 25 years. The rental for the total period is £27.5 million. The lease came into effect at the end of June 2020.

73

25 Related party transactions

The Royal College of Physicians (RCP), a charity registered (charity number 210508) in England and Wales, is the ultimate controlling parent of its subsidiary undertaking The RCP Regent’s Park Limited, which is consolidated on a line-by-line basis in these group accounts. The total transactions in the year from the RCP Regent’s Park Limited to the RCP totalled £10.4k, with the RCP as at 31 December 2025 owing the trading company £1,638k in relation to an intercompany balance.

No donations (2024: £333) were received from trustees in the year (2024: 2).

Senior officers work on behalf of the RCP undertaking national and regional work for the wider benefit of the public and of health services. In their positions as senior officers, the RCP makes a contribution directly to their employer (trust/university) to allow them to free up senior officers to be able to fulfil this important role. Senior officers do not receive any remuneration for their role as senior officers. Senior officers also hold roles as trustees, and it is this role that is deemed a related party. Contributions to organisations for trustee time spent on RCP activities amounted to £161k (2024: £172k) comprising: Milton Keynes University Hospital NHS Foundation Trust £31k (2024: £31k), East Lancashire Hospitals NHS Trust £18k (2024: £30k), Manchester University NHS Foundation Trust £50k (2024: £12k), King’s College Hospital NHS Foundation Trust £30k (2024: £22k), Velindre University NHS Trust £12k (2024: £0k) and University of Liverpool £20k (2024: £8k). A payment of £44k was made in the year to the legal advisers of a former trustee of the charity, Dr Sarah Clarke, to cover fees in relation to a legal claim. There were no other related party transactions in the period.

26 Capital commitments

As at 31 December 2025, the Royal College of Physicians held capital commitments of £154k (2024: £220k), relating to the migration of the customer relationship management (CRM) system to the cloud and the upgrade of the finance system to Business Central.

The Federation held capital commitments of £385k, primarily associated with the development of the exam management system and the CPD portfolio.

27 Contingent liability

The organisation has received a Letter of Claim relating to a historic matter. The claim is at an early stage, liability is not admitted, and no reliable estimate of the potential financial effect can be made at present.

74

28 Comparative notes from the prior year

Consolidated statement of financial activities for the year ended 31 December 2024

Unrestricted Restricted Endowment Total funds Total funds
Notes funds funds funds 31 Dec 24 31 Dec 23
£000 £000 £000 £000 £000
Income from:
Donations, grants and legacies 2 341 8 - 349 498
Charitable activities
Educating 3 19,207 13 - 19,220 18,601
Improving 4 3,825 1,732 - 5,557 5,222
Influencing 5 10,675 93 - 10,768 10,372
Activities togenerate funds
Investment income 6 376 40 232 648 643
Tradingactivities 23 6,417 - - 6,417 5,979
Other income 7 1,410 - - 1,410 1,160
Total income 42,251 1,886 232 44,369 42,475
Expenditure on:
Raising funds
Fundraisingcosts 405 - - 405 419
Investment management fees 48 2 48 98 150
Tradingactivities 23 5,941 - - 5,941 5,321
Charitable activities
Educating 8 22,119 261 12 22,392 22,193
Improving 9 5,745 1,815 31 7,591 6,928
Influencing 10 8,004 127 - 8,131 8,112
Other 170 - - 170 136
Total expenditure 11/12 42,432 2,205 91 44,728 43,259
Net operating (loss)/gain (181) (319) 141 (359) (784)
Netgains on investment assets 14 915 44 868 1,827 1,582
Net income/(expenditure) 734 (275) 1,009 1,468 798
Transfers between funds 19/20/21 558 (55) (503) - -
Actuarial (losses)/gains on defined benefitpension scheme 23 (328) - - (328) (1,146)

75

Unrestricted Restricted Endowment Total funds Total funds
Notes funds funds funds 31 Dec 24 31 Dec 23
Net movement in funds for theyear 964 (330) 506 1,140 (348)
Funds brought forward at 1 Jan 2024 18/19/20 31,453 2,449 12,620 46,522 46,870
Funds carried forward at 31 December 2024 32,417 2,119 13,126 47,662 46,522
20 Restricted funds Balance at Income
Expenses
Gains/(losses)
Transfers
Balance at 31/12/2024
01/01/2024
£000 £000
£000
£000
£000
£000
DorothyWhitneyWood – Physicians’ Fund 431 -
(70)
-
-
361
National RespiratoryAudit Programme 22 1,010
(990)
-
-
42
Falls and FragilityFracture Audit Programme - 722
(706)
-
-
16
Physicians’ Fund 34 -
-
-
-
34
Advanced clinicalpractice curricula development 71 -
-
-
-
71
The Saltwell Will Trust Research Branch 197 -
-
-
25
222
Research courseproject 176 10
(166)
-
-
20
Harold Thomas Barten Trust 123 2
-
8
-
133
Dr Everley-Jones legacy 101 2
-
7
-
110
KSS Clinical Education Fellowship 52 -
(52)
-
-
-
External Affairs – Alcoholproject 97 93
(127)
-
-
63
Medical Care 84 -
-
-
(84)
-
Sustainabilityfellow 65 -
(5)
-
-
60
Pulmonary Rehabilitation Services Accreditation
Scheme
31 -
(3)
-
-
28
E-learningfor healthcare – acute medicineproject 32 -
(32)
-
-
-
Catherine Mills Bequest 83 1
-
6
(5)
85
Thomas Cotton Trust 83 -
-
-
4
87
Frank Peacock Bequest 75 1
-
5
-
81
QIPS –patientpartners/medication safety 45 -
-
-
(23)
22
Queenie Louisa Higgins Bequest 54 1
-
4
(10)
49
Drabu MTIprogramme 5 -
-
-
2
7
Mackenzie-Mackinnon Streatfield 37 1
-
2
-
40
Fundraising 35 -
-
-
-
35
Eric Watts donation 13 -
(36)
-
23
-
Symons collection 34 -
-
-
-
34

76

20 Restricted funds
Balance at
01/01/2024
Income
Expenses
Gains/(losses)
Transfers
Balance at 31/12/2024
20 Restricted funds
Balance at
01/01/2024
Income
Expenses
Gains/(losses)
Transfers
Balance at 31/12/2024
Will Edmonds Clinical Research Trust
53
28
-
-
10
91
FundraisingHeritage Museum
34
-
-
-
-
34
28 other funds balances below £30,000
382
15
(18)
12
3
394
Total
2,449
1,886
(2,205)
44
(55)
2,119
21 Endowment funds
Unapplied
total return
01/01/2024
Income
Gains/(losses)
Conversion
to income
Transfers
Unapplied total
return
‘Frozen’
permanent
capital
Total
endowment
31/12/2024
31/12/2024
31/12/2024
£000
£000
£000
£000
£000
£000
£000
£000
Bradshaw Trust
214
6
24
(6)
-
238
143
381
Eden Fellowshipin Paediatrics
1,304
26
98
(5)
-
1,423
142
1,565
John Rosser Scholarship
40
1
6
-
-
47
42
89
Joseph Senior White Trust
142
5
21
(1)
-
167
161
328
Lewis Thomas Gibbon Jenkins-Briton Ferry
1,672
53
199
(12)
-
1,912
1,250
3,162
ORL Wilson Bequest
129
3
12
(1)
-
143
44
187
James Maxwell Grant Prophit Bequest
525
19
73
(34)
(7)
576
539
1,115
Sadleir Trust
429
9
35
(2)
(54)
417
91
508
Samuel Leonard Simpson Fellowship
750
19
70
(8)
-
831
280
1,111
TK Stubbins Bequest
19
2
8
-
-
29
104
133
Watson Smith Trust
681
21
78
(4)
(280)
496
470
966
William WitheringPrize
161
4
14
(1)
-
178
38
216
Dr JD RamsayScholarship
59
2
5
(2)
-
64
30
94
Graham Bull Prize
61
2
6
-
-
69
25
94
Sir Michael Perrin Lecture
89
2
7
-
-
98
12
110
LadyTeale Lecture
116
2
11
(1)
(117)
11
44
55
John Glyn
123
3
14
(4)
-
136
80
216
Dame Sheila Kift Bequest
46
2
6
-
-
54
38
92
John Thornton Ingram Lecture
38
1
3
-
-
42
6
48
Lockyer Lectureshipand Fellowship
33
1
3
-
-
37
12
49
Simms Bequest
28
1
3
-
-
32
16
48
Professor PF Thomas Bequest
33
1
4
-
-
38
25
63
10 other funds with balances below
£40,000
70
2
8
(1)
-
79
50
129
Subtotal
6,762
187
708
(82)
(458)
7,117
3,642
10,759

77

Funds not included in total return Balance at
01/01/2024
Income Gains/(losses) Conversion to
income
Transfers ‘Frozen’
permanent
capital
Balance at 31/12/2024
£000 £000 £000 £000 £000 £000 £000
Thomas Cotton Fund 203 4 4 - (4) - 207
The London Fever Hospital Research Fund 189 4 15 (1) (4) - 203
Saltwell Will Trust Research Branch 1,167 25 93 (5) (25) - 1,255
Will Edmonds Clinical Research Fund 526 10 39 (2) (10) - 563
Drabu Fund 131 2 9 (1) (2) - 139
Subtotal 2,216 45 160 (9) (45) - 2,367
Total endowment 8,978 232 868 (91) (503) 3,642 13,126
22 Analysis of group net assets after pension scheme liability 22 Analysis of group net assets after pension scheme liability 22 Analysis of group net assets after pension scheme liability 22 Analysis of group net assets after pension scheme liability 22 Analysis of group net assets after pension scheme liability
Intangible and tangible
assets
Investments Net liabilities inc
pension liability
Total
2024
Total
2023
£000 £000 £000 £000 £000
Unrestricted:
Designated Fixed Assets Fund 24,840 - - 24,840 25,662
Legacies Development Fund - - 120 120 120
CareQualityImprovement - - 18 18 18
Maintenance Fund - - 240 240 160
JAG Fund - - 205 205 345
24,840 - 583 25,423 26,305
General funds - 15,752 (8,758) 6,994 5,148
24,840 15,752 (8,175) 32,417 31,453
Restricted - 1,644 475 2,119 2,449
Endowment - 11,870 1,256 13,126 12,620
Total 24,840 29,266 (6,444) 47,662 46,522

78

Awards, fellowships and donors

Awards, prizes and medals

Excellence in Patient Care Awards

The Alliance Medical Health inequalities award Sandwell and West Birmingham Hospitals NHS Trust

The Lean enabled service improvement award DISCARD3 (St Mark’s Hospital) and NHSE Optical Diagnosis Implementation teams

Sustainability award

University Hospital Plymouth NHS Foundation Trust and Amicus Health (Tiverton)

The Medical Protection Society award for patient safety Croydon University Hospital

Research award – expanding medical knowledge while improving patient care Great Ormond Street Hospital and University College London

Chief registrar project of the year

Gloucestershire Royal Hospitals NHS Foundation Trust

Ambuj Nath Bose prize Dr Nageshwar Reddy

Bisset Hawkins prize Dr Neeraj Bhala

Graham Bull Prize, Goulstonian lecture Dr Amit Sud

Lewis Thomas Gibbon Jenkins of Briton Ferry fellowship

Dr Sumana Vasishta (awarded in 2024, continuing her 2-year project)

Medical student elective bursaries

Rossel Ahmad Mehar Bijral Caleb Cole Lucas Heeringa Zain (Syed) Jafri Eleanor Kerr Ritu Khanna Shameer Mohamed Naleer Aoife O’Donnell Sanjay Rajput Aleksander Sulkowski

Gilbert Blane trust prize

The Alliance Medical education award – improving patient focus DigiBete CIC and NHS England Diabetes team

The Medical Practice Management award for developing workforce The Rotherham NHS Foundation Trust

The Harold Thimbleby award for digital transformation

Chelsea and Westminster Hospital NHS Foundation Trust

The Eric Watts award for patient engagement Cwm Taf Morgannwg University Health Board

Surgeon Lieutenant-Commander Louise McMenemy

Virtual poster competition

Dr Pharveen Jaspal Dr Dominic Mears Dr Ioannis Perros Dr Yee Mon Thu

Teale essay prize Dr Arrash Fattahi

Fellowships and bursaries

Whitney Wood fellowship Dr Faiz Jabbar

Wolfson intercalated awards

In 2025 we awarded 45 intercalated grants of £5,000 across 25 medical schools.

Lectureships

Croonian lecture

Professor Debbie Shawcross

FitzPatrick lecture

Dr Jack Parry Jones

Harveian Oration Professor John Feehally

Linacre lecture

Dr David Lindsay

79

Major donors and sponsors for 2025

Sir Michael Perrin lecture Professor Paul Boon

Samuel Gee lecture Professor Fliss Murtagh

Individuals, including legacies

Lady Estelle Wolfson Estate of the late Dr Graham Robert Harlow Estate of the late Dr Krystyna Czapla

Trusts and foundations

Turner-Warwick lectures

Dr Jun Yu Chen Dr Sarah Bowers Dr Stephen Joseph

Fellowship admissions

New fellows

375 elected under bye-law 8.2 (1) a 0 elected under bye-law 8.2 (1) b 411 elected under bye-law 8.2 (1) c 1 elected under bye-law 8.2 (1) d 0 elected under bye-law 8.6 (1)

The Wolfson Foundation

Corporate grants

Pfizer Norgine UCB Otsuka Pharmaceuticals Pharmacierge

Corporate sponsorship

Accurx AstraZeneca Bayer Boehringer Ingelheim Eli Lilly & Co GSK

80

Administrative information

Principal address

11 St Andrews Place Regent’s Park London NW1 4LE

Santander UK plc Education Specialist Sectors Group 4 St Paul’s Square Liverpool L3 9SJ

Principal advisers

Solicitors

Fieldfisher LLP Riverbank House 2 Swan Lane London EC4R 3TT

DAC Beachcroft LLC Administration Centre Portwall Place Portwall Lane Bristol BS1 9HS

Bankers

C Hoare and Company 37 Fleet Street London EC4P 4DQ

Lloyds plc National Clubs and Charities Centre Sedgemoor House Dean Gate Avenue Blackbrook Business Park Taunton TA1 2UF

Auditor

Crowe U.K. LLP 55 Ludgate Hill London EC4M 7JW

Investment managers

Cazenove Capital Management 12 Moorgate London EC2R 6DA

Morgan Stanley Private Wealth Management 25 Cabot Square Canary Wharf London E14 4QA

Royal Bank of Canada 1 Place Ville Marie 12th floor Suite 1240 Montréal Quebec H3B 4P5 Canada

81

CONNECTION STANDARDS VOICE RENEWAL CONNECTION STANDARDS VOICE RENEWAL CONNECTION STANDARDS VOICE RENEWAL CONNECTION STANDARDS VOICE RENEWAL CONNECTION STANDARDS VOICE RENEWAL CONNECTION STANDARDS VOICE RENEWAL CONNECTION STANDARDS VOICE RENEWAL CONNECTION STANDARDS VOICE RENEWAL CONNECTION STANDARDS VOICE RENEWAL

comms@rcp.ac.uk Published: August 2026 © Royal College of Physicians 2026